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The fluorine-containing functional group Ar-CFHCF3 is potentially useful within the 
pharmaceutical, agrochemical and polymer industries if synthetic methodology is 
available for the synthesis of these systems. Here, a new general synthetic pathway for 
the synthesis of 1-aryl-1,2,2,2-tetrafluoroethanes starting from either benzaldehyde or 
3-pyridinecarboxaldehyde derivatives is presented.  
 
Reactions of aldehydes with CF3SiMe3 and a catalyst of TBAF (tetrabutylammonium 
fluoride) and then DAST (diethylaminosuphur trifluoride) were generally very efficient 
for a range of substrates bearing electron donating/ withdrawing substituents on the 








Chapter 1: Organofluorine chemistry and trifluoromethyl-containing 
aromatic systems 
1.1 Organofluorine chemistry 
Organofluorine chemistry is focussed on organic molecules that contain at least one 
single bond between a carbon and a fluorine atom. The addition of fluorine to an organic 
molecule to replace a hydrogen atom does not have a major steric effect because the 
van der Waals radius of a fluorine atom (1.47 Å) is between the sizes of a hydrogen atom 
(1.09 Å) and an oxygen atom (1.52 Å). Additionally, the C-F bond length (1.35 Å) is 
between that of the C-H (1.09 Å) and C-O (1.43 Å) bond lengths. On the other hand, 
there is a large electrostatic effect on a molecule following replacement of H and F 
because fluorine is the most electronegative element (on the Pauling scale of 
electronegativities F = 4.0, H = 2.1 and O = 3.5). This effect would be greatest when the 
addition of a fluorine atom is to a non-polar molecule or the non-polar region in a larger 
system1. The changes in molecular properties caused by the presence of C-F bonds 
compared to their C-H analogues can significantly change chemical, biological and 
physical properties, giving rise to unusual and valuable systems. Consequently, next we 
will discuss further the effect of fluorine atoms on molecular properties and the use of 
fluorinated systems in pharmaceutical applications. 
1.1.1 Effect of fluorine on molecular properties 
1.1.1.1 Effect of fluorine on inter- and intra-molecular interactions 
Adding fluorine to organic molecules can influence intramolecular or intermolecular 
interactions. For intramolecular interactions, fluorine causes a decrease in polarity of 
nearby polar covalent bonds between two bonded atoms that have a difference in 
electronegativities between 0.5 - 1.9, so that the electron density between those two 
atoms is shifted towards the more polar atom of that covalent bond (fig. 1). 
 
 
Figure 1-the effect of fluorine on nearby polar groups within a molecule2-3 
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Alongside this, fluorine can increase intramolecular forces (between other bonded 
atoms) due to high fluorine electronegativity, which slightly changes the polarity of 




In terms of intermolecular bonding, it is possible for fluorine to be involved in 
hydrogen bonding (C-F…H) due to the difference of electronegativities between H and F. 
However, fluorine can only be involved in weak hydrogen bonding as, unlike oxygen and 
nitrogen, its high electronegativity means it has poor polarizability. Thus, organofluorine 
moieties are hydrogen acceptors and bad donors. Furthermore, fluorine will reduce the 
maximum potential energy of intermolecular London dispersion forces as there is a 
smaller chance and smaller potential energy of a temporary induced dipole because 
fluorine is the least polarizable element. 
It is possible for fluorine to both increase and decrease dipole-dipole interactions of 
a molecule. Addition of fluorine to a non-polar molecule can induce such dipole-dipole 
interactions as the C-F bond contains a large dipole. Fluorine can increase a pre-existing 
dipole-dipole interaction when it is added to a molecule already containing a polar group 
(e.g. OH, NH or Cl). Furthermore, fluorine can increase such interactions, and even make 
a molecule appear more polar, when fluorine is added at the opposite end of a molecule 
containing an electropositive element such as silicon or phosphorus. However, when 
fluorine is attached to the same or adjacent carbon to an element with a lower 
electronegativity than carbon, then the dipole-dipole will be reduced and may even be 
lost completely. These effects show that a C-F bond can bring about large charge-dipole 
interactions even when hydrogen bonding is not likely.1 
1.1.1.2 Carbon-Fluorine bonds 
The high electronegativity of fluorine affects the bonding interactions of a molecule 
and has direct influence on the reactivity of a C-F bond. The C-F bond is highly polarized 







leading to a low lying σ* orbital and fluorine is a poor π donor so the formation of a C=F+ 
system is highly unlikely (fig. 3).  
 
 
The C-F bond has the highest bond dissociation energy (105.4 kcal mol-1) of all single 
covalent bonds to carbon and, this effect is primarily seen in the high stability of many 
fluoropolymers.1 
Since the C-F bond is very strong, F- is a poor leaving group in SN2 reactions. F- is not 
formed in this type of reaction because of the almost ionic-like C-F bond. However, there 
is one type of substitution reaction that is possible and that is aromatic nucleophilic 
substitution (fig. 4). Fluorine stabilises the carbanionic intermediate and leaves as 
fluoride to allow the aromatic ring to reform. Also, one consistently possible way for F- 
to be a leaving group is via an E1CB process to form an alkene. A base must cleave the 
beta-hydrogen atom to form the carbanionic intermediate which is stabilised by 









Figure 3- Unlikely formation of the C=F+ system 




1.1.1.3 The effects of fluorine on lipophilicity 
Lipophilicity is the relative solubility of an unionized compound between organic and 
aqueous phases (i.e. octanol and water) at equilibrium. This is expressed as the partition 
coefficient (log P) between octanol and water. Lipophilicity can be affected by pH 
especially when a molecule contains ionizable groups (i.e. OH, NH2) and this can be 
quantified by the distribution coefficient (log D) which measures log P at differing pH 
values.10 Pharmaceutical molecules need to pass through cell membranes into the lipid 
core and then not become trapped in it. This is part of the passive transport for orally-
administrated drugs which are absorbed and distributed throughout the body. For 
effective drugs, molecules cannot have a log P > 5 otherwise there would probably be 
poor absorption. This comes from the Lipinski “rule of 5”10. The poor absorption would 
mean that the molecule is not effective at getting through the cell membrane because 
it is too soluble in water. Fluorination generally leads to an increase in lipophilicity, but 
not always. Fluorination on an aromatic ring or adjacent to a π-system will increase the 
lipophilicity because of the low polarizability of the C-F bond. In saturated alkyl groups, 
a decreased lipophilicity is observed when it undergoes monofluorination or 
trifluoromethylation.10,11,12 
A problem for many drugs is their metabolic oxidation by cytochrome P450 enzymes, 
thus decreasing lipophilicity. This means that molecules can, therefore, be easily 
excreted before it reaches its target and have its desired effect. To prevent this, the 
metabolically-liable sites can be blocked by fluorine substitution. Replacing a methyl or 
methoxy group with a fluorinated group can prevent this reaction. An example of this in 
practice is the antidepressant drug Rolipram, which was optimised by replacing methoxy 
and cyclopentoxide substituents with difluoromethoxy groups as well as protecting the 
para position on the phenyl ring with by a di(trifluoromethyl)methoxy group (fig. 5).  
 
Figure 5- Lead optimisation of Rolipram, in part by fluorinations11 
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1.2 Organofluorine systems in pharmaceuticals 
Fluorine has several uses in pharmaceuticals. Firstly, fluorine-containing groups can 
stabilise biologically active systems so they have a longer lifetime in the body. This 
improved bioavailability is caused by the strong C-F bond that allows a greater 
permeability throughout the body owing to a lower metabolic clearance rate.11 
Ezetimib, a plasma cholesterol lowering drug (fig. 6), had to be doubly fluorinated to 
prevent oxidation of both the pendant phenyl position and the methoxy group to 





Thalidomide has both the useful R-enantiomer, which is used as a treatment of 
morning sickness, and the unwanted S-enantiomer which is a potent teratogen. 
However, the enantiomers can interconvert in vivo. This can be prevented by replacing 
the acidic hydrogen on the chiral centre with a fluorine which prevents epimerisation 





Another use of fluorine is that 18F can be used to track a drug’s passage through the 
body via positron emission topography (PET) to assess the lifetime of the drug to help 
decide an appropriate dosage. 18F glucose is a radiopharmaceutical (fig. 8) that is used 
in medical imaging and positron emission and is used to measure the uptake of glucose 
in tissues. This makes it a good compound for cancer detection because 18F glucose 
accumulates in tumours.11  
Figure 6- Lead optimisation of Ezetimib, in part by fluorination11 
(R) 






Aprepitant is an antiemetic compound that blocks the neurokinin 1 receptor. 






The addition of the fluorine(s) can reduce the pKa of a drug which will make it more 
stable to acids within the body13. When 3-piperidinylindole, an antipsychotic, is 








Some examples of fluorine being used in drugs are shown in fig. 11: fludrocortisone,14 
which increases the bioactivity by an order of magnitude; lipitor14-15 (atorvastatin), 
which is used as a cholesterol inhibitor by blocking the in vivo cholesterol biosynthesis; 
prevacid16 (Lansoprazole) that is used for stomach acid/ ulcers via undergoing an acid 
catalysed rearrangement to produce a sulfenamide which reduces gastric acid secretion; 
and Efavirenz16 is an anti-HIV agent that stops the reverse transcriptase enzyme which 
Figure 8- Structure of 2-Deoxy-2-[18F]fluoro-D-glucose11 
Figure 9- Structure of [18F]SPA-RQC and Aprepitant11 
Figure 10- Reduced pKa on the fluorination of 3-piperidinylindole antipsychotic drugs11 
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prevents the HIV’s genetic code. As well as molecules containing one C-F bond, many 







Trifluoromethyl groups are attached to many drug systems. When CF3 is directly 
attached to an aromatic ring it is meta-directing in electrophilic substitution processes 
and has a long-range electron withdrawing effect because of the three fluorine atoms. 
Some important CF3-containing pharmaceuticals are listed in figure 11. 
The trifluoromethoxy group can lower molecular dielectric constant and surface 
tension properties.17 Furthermore, it can promote in vivo uptake and transport in 
biological systems as well as promoting binding affinities because OCF3 has an excellent 
lipophilicity. This is shown from the Hansch-Leo parameter πx (OCF3) = +1.04 and is 
further highlighted by having a better parameter than for CF3 (πx (CF3) = +0.88).17 
Therefore, adding an OCF3 group to a molecule will not decrease lipophilicity as much 
as a CF3 group. Just like with the CF3 group, the trifluoromethoxy group could be added 
to increase the metabolic stability of the pharmaceutical compound. Trifluoromethoxy 
has an even further long-range electron withdrawing effect then a trifluoromethyl group 
because of the additional oxygen. This group is present in the pharmaceutical compound 
Riluzole, which is used in the treatment of amyotrophic lateral sclerosis (fig. 12). A 
further example of a pharmaceutical molecule containing a trifluoromethoxy group is 
Sonidegib which is an anticancer agent (fig. 12). 
 








CF2H groups can also make molecules more lipophilic as it is a hydrogen-bond donor 
and can act as a bioisostere for both alcohols and thiols.19 The group has also been 




Eflornithine Hydrochloride is used to treat African trypanosomiasis (sleeping 
sickness) as well as excessive hair growth (fig. 13). Pantoprazole is used as a proton 
pump inhibitor to treat certain stomach and esophagus problems (fig. 13). The synthesis 
of some of these fluorinated functional groups (CF3, OCF3) will be discussed in more 
detail in the following section. 
1.3 Trifluoromethyl derivatives in organic chemistry 
To synthesis a molecule containing a CF3 group can be done via C-F bond formation 
or a trifluoromethylating agent. There are three types of trifluoromethylating agents 
which are electrophilic, nucleophilic, and free radical.23,24,35 
1.3.1 Synthesis of CF3 groups by C-F bond formation 
To form trifluoromethyl compounds via C-F bond-forming reaction, synthesis 
generally starts with either an α,α,α-trihalide (i.e. Cl or Br) or a carboxylic acid 
containing-compound. The transfer of α,α,α-trihalides to trifluoromethyl compounds 
can be done on both aryl and alkyl systems using Swarts23-24 reactions (SbF3 + SbCl5) or 
anhydrous hydrofluoric acid (HF). The Swarts reaction on α,α,α-trihalides is problematic 
because after each successive halogen exchange the ability of chlorine to act as a donor 
to the catalyst diminishes. To accommodate for this, high temperatures and pressures 
Figure 12- Structures of Riluzole and Sonidegib17-18 
Figure 13- Structures of efornithine and pantoprazole21-22 
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are used. The alternative to a Swarts reaction is the use of HF, but this reagent is even 









Another CF3-forming reagent is SF4 (fig. 15). It is a deoxyfluorinating agent for 
carboxylic acids with a catalytic amount of HF. Initially the reaction forms the acid 





Again, SF4 and HF are both hazardous and, therefore, can be unsafe for laboratory 
use or late-stage pharmaceutical molecule synthesis. A milder form of the SF4 reagent is 
DAST (diethylamino sulfur trifluoride). However, DAST would only form the acid fluoride 
(figure 15) as it is quite unreactive in comparison to SF4. DAST is a nucleophilic 
fluorinating agent which fluorinates by a SN2 type pathway. The general uses of DAST 
are to replace a hydroxy group with a fluoride ion, to change an aldehyde to a geminal 
Figure 14- Examples of syntheses to form the -CF3 functional group via C-F bond formaton25-26 
Figure 15- SF4 mechanism and example synthesis for forming the -CF3 functional group27-28 
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difluoride group or to convert ketones to a difluoride functional group. When going from 








A few examples of where DAST has been used in synthesis are shown in figure 
16: cyclohexanol,29 diethyl (4-methylbenzoyl) phosphonate30 and 3-(3,4-
dimethoxyphenol)-1-propanol (a primary alcohol).31 These reactions were carried out in 
DCM (Dichloromethane) and at temperatures starting from 0 oC to room temperature. 
This temperature range is used because DAST decomposes at 90 oC to give sulfur 
tetrafluoride and bis(dimethylamino)sulphur difluoride with the latter being 
explosive.32-35 
1.3.2 CF3 nucleophilic insertion 
Trifluoromethylating agents are generally quite useful for laboratory use as well as 
late-stage functionalisation of complex pharmaceuticals, because they are not as 
hazardous and do not require harsh reaction conditions. Three useful 
trifluoromethylating agents are trifluoromethyl iodide,36 trifluoroacetonitrile,37 and 
sodium acetate.38 Trifluoromethyl iodide requires a solvent of DMF (dimethyl 
formamide) and a light source to initiate the catalyst tetrakis(diethylamino) ethylene to 
form the trifluoromethyl anion in situ which can then attack the carbonyl group (fig. 17). 
 
Figure 17- Mechanism for CF3 addition from trifluoromethyl iodide36 
Figure 16- Example synthesises using the nucleophilic fluorinating agent DAST29-31 
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Trifluoroacetonitrile requires a solvent of dry THF with a catalyst of DBU (1,8-
diazabicyclo(5.4.0)undec-7-ene) on polystyrene (PS)). This reagent adds 1-diazo-2,2,2-
trifluoroethane to a carbonyl group (fig. 18). 
 
 
Sodium trifluoroacetate can be used to replace halides with a CF3 group (fig. 20). It is 
made initially from electrofluorination of acetyl chloride to give trifluoroacetyl fluoride, 
which is then followed by a hydrolysis to give trifluoroacetic acid. Next, sodium sulfate 
is dissolved in trifluoroacetic acid to give sodium trifluoroacetate.39 The nucleophilic CF3 
agent was then dissolved in DMF before being heated enabling a decarboxylation 
reaction to give sodium trifluoromethanide, which could then react with a carbonyl 





A more effective nucleophilic trifluoromethylating agent, TMSCF3, can be used and 
many reviews have described the use of this Ruppert-Prakash reagent. The reagent can 
be used in a variety of reactions and, for all the reactions with this reagent, there needs 
to be an initiator (catalyst). The CF3- nucleophile has a good working range where it can 
be effective at low and high temperatures depending upon the number of available 
electrophilic sites, type of initiator used and/ or the steric and electronic effects of a 
substrate. 
TMSCF3 can react with a variety of electrophilic functional groups such as halides, 
imines, ketones and aldehydes. Halides react with TMSCF3 and for this reaction there 
needs to a catalyst of copper(I) thiophene-2-carboxylate and a potassium fluoride 
initiator (fig. 21&22). 
Figure 19- Mechanism for CF3 addition from sodium trifluoroacetate38 
Figure 18- Reaction using trifluoroacetonitrile37 







Cyclic imines, azirines and aldimines as well as cyano and amide functional groups 
can react with TMSCF3 and these reactions generally have an initiator of 
tetrabutylammonium fluoride (TBAF), tetramethylammonium fluoride (TMAF), caesium 













Figure 24- TMSCF3 reaction with cyano and amide groups41 
Figure 22- Copper-catalysed TMSCF3 reaction with halide 241 
Figure 23- TMSCF3 reaction with imides41 
Figure 21- Copper-catalysed TMSCF3 reaction with halide 141 
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 The most important electrophilic groups that react with TMSCF3 are carbonyl groups 
(i.e. ketones and aldehydes). They also require an initiator such as sodium acetate 
(NaOAc), TMAF, TBAF, HF, CsF or potassium hydroxide (KOH) to enable their reaction. 
Generally, dry tetrahydrofuran (THF) or N,N-dimethyl-formamide (DMF) are used as 







The ketone will normally react more slowly than an aldehyde. So, for aldehyde 
reactions there needs to be less heating or less catalyst for reactions to go to 
completion. Benzaldehyde reacts to form the trifluoromethyl alcohol43 and some 










Figure 25- TMSCF3 reactions with ketones41,42 




1.3.3 CF3 radical insertion 
A third way a CF3 group can be added to a molecule is via radical insertion. This is 
where the connecting bond to the CF3 is cleaved via a photo-induced homolytic fission. 
Alternatively, a precursor reaction could make a hypervalent copper species which could 





1.4 Trifluoromethoxy derivatives in organic chemistry 
There are two mains ways to add the OCF3 functional group to a molecule and they 
are by C-F bond formation or via OCF3 insertion using both CF3O+ and CF3O- reagents. 
The first way to form the OCF3 moiety is by C-F bond forming reactions which is similar 
to when forming the CF3 functional group. This can be done by SN2 reactions with 
carbonyl fluoride, thiophosgene, carbon tetrachloride or iodomethane. Next are 
reactions of methoxy groups with a mix of PCl5 (phosphorus pentachloride) and Cl2 
(elemental chlorine) to form the OCl3 functional group which is easier to convert to the 
OCF3 functional group. As above in section 1.3.1, SF4, HF, SbF3/ SbCl5 and BrF3 are used 
to form the C-F bonds. Below are examples of forming the OCF3 functional group by C-F 







Figure 27- Hypervalent copper CF3 radical insertion reactions24 
Figure 29- Synthesis of trifluoromethoxy benzene via HF46 










Another way to add OCF3 to a molecule is via trifluoromethoxy insertion. First this can 
be done as CF3O+ reagents such as CF3O-F (trifluoromethyl hypofluorite) or CF3O-Cl 
(trifluoromethyl hypochlorite),47 which must be made in situ. These reagents are 
kinetically stable, but not thermodynamically stable so their concentration must be 
carefully controlled. These can react with alkenes, or phenyl rings (fig. 33-35). 
Trifluoromethyl hypofluorite is very explosive so has to be used at low temperatures 






    A further method for forming OCF3 compounds is via the use of silver 
trifluoromethoxide (CF3O-), which can be used in reactions with both aromatic and alkyl 
alcohols, haloalkanes and acid chlorides (fig. 36&37).                                            
     
 
Figure 31- Reaction for the formation of the trifluoromethoxy group via carbonyl fluoride45 
Figure 30- Synthesis of methyltrifluoromethyl ether via BrF346,47 
Figure 32-Synthesis of methyltrifluoromethyl ether via SF448 
Figure 33- Trifluoromethyl hypofluorite reacting with an alkene49 
Figure 34- Trifluoromethyl hypochlorite reacting with an alkene50 









The final way to add a CF3 group to a molecule is by ‘radical’ insertion where TMSCF3 
is used with silver triflate. When reacted with an alcohol forms a hypervalent silver 
complex which decomposes to give the trifluoromethoxy functional group (fig. 38). 
 
The following example (fig. 39) is a photo-induced radical insertion, which cannot go 
via a SN2 pathway because the three fluorine atoms all have partial negative charges, 






Figure 36- Example reaction of the silver trifluoromethoxide nucleophile52 
Figure 37- Example reaction for trifluoromethanol53 
Figure 38- Mechanism for the formation of the trifluoromethoxy group via silver trifluoromethoxide54 
Figure 39- Aromatic trifluoromethoxy formation via trifluoromethyl iodide55 
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1.5 Pentafluoroethyl derivatives in organic chemistry 
The pentafluoroethyl group has a lower electronegativity than for a CF3 group (3.4 < 
3.46)56 because there are less fluorines bonded to the primary carbon. The CF2CF3 
functional can be added to a molecule by C-F bond forming reactions or by nucleophilic 
-CF2CF3 insertion. For C-F bond formation this can be done on nitriles, carboxylic acids, 
perchloro alkenes and perchloro alkanes. They are generally carried with either HF or 
germanium tetrafluoride (GeF4). The reactions below all show the formation of 







A more general method to add CF2CF3 to a molecule is via pentafluoroethyl insertion. 
This is generally done via nucleophilic reagents such as TMSCF2CF3, CF3CF2I, CF3CF2Li and 
CF3CF2Cu, normally react with carbonyls and halides. These reagents are formed from 
pentafluoroethane as synthesized above. The first nucleophile is CF3CF2I, which is 
formed from either from pentafluoroethane, tetrafluoroethylene (TFE) or 
perfluoropropanoyl fluoride. Shown below are the different ways of forming 

















The figure below shows a couple of examples for the use of CF3CF2I. The first example 
is of a radical substitution on an alkene (fig. 42) and the second example is of a 
nucleophilic attack on a ketone (fig. 43). 
       
     
        
    
The remaining three nucleophiles TMSCF2CF3, CF3CF2Li and CF3CF2Cu are all formed 
via a very similar pathway. TMSCF2CF3 is made via a reaction between 
pentafluoroethane and trimethylsilyl chloride (TMSCl); examples of some conditions 
used to make this reagent are given in fig. 44. 
 
 
Figure 42- Radical CF3CF2 insertion65 
Figure 43- Nucleophilic CF3CF2 insertion from ICF2CF366
 









A third CF3CF2- nucleophile is LiCF2CF3, which is generally made in situ because it is 
not very stable above –70 oC. The nucleophile can be trapped by TMSCl to give TMCF2CF3 




CF3CF2I is a better reagent because it is safer to transfer and handle and below is an 




CF3CF2Cu is formed via a reaction between the lithium nucleophile and a copper 




Figure 44- Current synthetic pathways to form TMSCF2CF367-69 
 Figure 45- Mechanism for transforming pentafluoroethane to TMSCF2CF367 
Figure 47- Nucleophile CF3CF2 insertion from CuCF2CF3 71 




Of the compounds listed above TMSCF2CF3 is the best nucleophile for synthetic use 
because it is usable at room temperature and is bench stable. As with CF3TMS it would 
require a fluoride source, such as TBAF, to act as an initiator.  
TMSCF2CF3 can be used in the same reactions as TMSCF3, but it is a weaker 
nucleophile and significantly bulkier.  For -CF2CF3 reactions, this means that more TBAF 
and TMSCF2CF3 are needed (relative to the substrate) to ensure sufficient conversions.  










1.6 Synthesis of Ar-CFHCF3 functional group 
In this thesis, we develop methods for forming Ar-CHFCF3 systems. Consequently, we 
discuss methods in the literature for synthesis of ArCFHCF3 derivatives. This functional 
group has not been studied to any great extent in the pharmaceutical, agricultural and 
polymer industries.  
The first method reported to form the –CFHCF3 group started with a benzylic diazo 
group which reacted with HF pyridine in DCM, under an inert atmosphere, in a sealed 
tube and at 0 oC35 (fig. 51). This method it has been done for methyl, nitro, methoxy and 




Figure 51- Formation of the Ar-CHFCF3 from a diazo group35 
Figure 50-TMSCF2CF3 reacting with an aldehyde74 
Figure 48- TMSCF2CF3 reacting with a difluoroalkene72
 
Figure 49- TMSCF2CF3 reacting with a ketone73 
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This method is not very good for laboratory use because the diazo functional group 
is very unstable at room temperature.  
The second method reported to form the ArCFHCF3 group was by a reaction between 
1-phenyl-2,2,2-trifluoroethanol and diphenylsulphur (VI) oxide difluoride in DCM at 25 
oC. This dehydroxy-fluorinating agent is made by reaction between 1,1’-
sulfinylbisbenzene and xenon difluoride in DCM with a catalyst of tetraethylammonium 
chloride.75 The fluorinating agent must then be stored at low temperature and under an 
inert atmosphere. This is because it will readily react with water to produce HF. Below 








Once the attack by the alcohol has occurred, the fluoride ion is released to form HF 
making the first step irreversible. The slow step is the SN1 release of the second fluoride 
ion and then the final fluoride attack is fast.  
The final method to turn the trifluoromethyl alcohol into the desired functional group 
uses DAST. It is dehydroxy-fluorinating agent that must be dissolved in DCM before it is 
added to the reaction mixture at -70 oC before a reaction is allowed to warm to 20 oC 
during the reaction31 (fig. 53). 
 
 
This reaction scheme was very similar to the processes carried out in this thesis. 
However, in the published paper only 3 examples of the ArCFHCF3 systems (Ar = Ph, 
Figure 53- Reaction scheme for DAST32,33 
Figure 52- Mechanism of fluorination from diphenylsulfur (VI) oxide difluoride75,76 
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CH3Ar, CH3OAr) were prepared and then used to make fluoro-substituted styrene 
monomers.  
1.7 Synthesis of Ar-CFHCF2CF3 functional group 
In this thesis, we also develop methods for forming Ar-CFHCF2CF3 systems. 
Consequently, we discuss here methods in the literature for synthesis of ArCFHCF2CF3 
derivatives.  
ArCFHCF2CF3 derivatives can be made via a variety of different methods that have 
been published and they all either start from benzaldehyde or benzoyl chloride/ ethyl 
benzoate. The hydroxy group can be converted to a fluorine atom via two different one 
step pathways.  
The first pathway reported to form the pentafluoroethyl-substituted alcohol is to first 
convert benzoyl chloride or ethyl benzoate to pentafluoroethyl phenyl ketone. This can 
be done either by reacting benzoyl chloride with pentafluoroethyl iodide with 
hexaethylphosphoric triamide in DCM (fig. 54) or by reacting ethyl benzoate and 
pentafluoroethyl iodide with a mixture of methyl lithium and lithium bromide in dry 





Next the ketone is reduced to the alcohol by reacting with a suitable hydride source. 
Two of the better options are to react with sodium borohydrate in methanol or lithium 





Figure 54- Different methods for making pentafluoroethyl phenyl ketone77-78 
Figure 55- Two methods to make 1-phenyl-2,2,3,3,3-pentafluoropropanol34,79 
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An alternative to making the pentafluoro-substituted alcohol is to start with 
benzaldehyde then react it with TMSCF2CF3 in dry THF or with pentafluoroethyl iodide 
with a mix of methyl lithium and lithium bromide in dry diethyl ether at -78 oC under a 





When the pentafluoroethyl-substituted alcohol had been formed it can be converted 
to the hexafluoro compound either using DAST in DCM or by FAR (the Ishikawa reagent, 






Organic molecules containing fluorine atoms, CF3 or OCF3 groups can be very valuable 
pharmaceuticals because of the change in physical, chemical and biological properties 
caused by fluorine atoms. 
There are many synthetic methods available for C-F bond formation as well as 
approaches to introduce CF3, and OCF3 groups into organic synthesis. 
In this thesis, we aim to develop methodology for the formation of aryl–CFHCF3 




Figure 57- Different methods for making 1-phenyl-1,2,2,3,3,3-hexafluoropropane34,81 
Figure 56- A further two methods to form 1-phenyl-2,2,3,3,3-pentafluoropropanol68,80 
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Chapter 2 Synthesis and Properties of ArCHFCF3 systems 
2.1 Aims and Approach: 
The main aim of this research is to develop a general synthetic pathway to synthesise 
ArCHFCF3 systems (fig. 58) and compare properties of ArCFHCF3 and ArCFHCF2CF3 
systems with corresponding ArCF3 and ArOCF3 derivatives. Further functionalization to 












The first target molecules were 1-phenyl-1,2,2,2-tetrafluoroethane derivatives and 
our strategy was a reaction between benzaldehydes and TMSCF3 with TBAF catalyst, 
before reacting the resulting trifluoromethyl-substituted alcohol with DAST (fig. 59). 
 
 
Figure 59- Proposed synthetic approach to make ArCHFCF3 derivatives 
Figure 58- Proposed overall experimental aims of this thesis 
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A variety of compounds containing the Ar-CHFCF3 functional group were to be 
synthesized with different functionalities. These analogues have different substituents 
in the para position of the phenyl ring, which were either electron donating or electron 
withdrawing groups.  
The initial target molecule, 1-phenyl-1,2,2,2-tetrafluoroethane, could then be 
reacted with electrophiles to see how susceptible the molecule is to electrophilic 
substitution processes (fig. 60). The kinetics of the electrophilic reaction would be 
studied via a kinetic comparison with two other aromatic systems, which contain 




Another aim of this project was to synthesise 1-(3-pyridyl)-1,2,3,3,3-
pentafluoroprop-1-ene using similar methodology to that developed above. The starting 
material would be 3-pyridinecarboxaldehyde, which would be reacted with TMSCF2CF3 
and a catalyst of TBAF before reacting the resulting trifluoromethyl substituted alcohol 
with DAST to form the hexafluoro compound. The hexafluoro compound could be 
reacted with potassium tert-butoxide to form the target molecule (fig. 61).  
 
 
2.2 Results and Discussion 
2.2.1 Reaction of benzaldehyde with TMSCF3 
The first target was the synthesis of unsubstituted ArCFHCF3 following the strategy 
discussed above. First, benzaldehyde and TMSCF3 were dissolved in dry THF at 0 oC 
before the addition of a catalytic amount of tetra-n-butylammonium fluoride (TBAF). 
The reaction was stirred continually, while it was warmed to room temperature. After 3 
hours the resulting benzyl-trimethylsilyl ether was hydrolysed by the addition of 6 M 
Figure 60- ArCHFCF3 electrophilic substitution pathway 




hydrochloric acid and allowed to stir for 48 hours to give 1-phenyl-2,2,2-trifluoro-
ethanol, 2a (fig. 62). This procedure was adapted from literature procedures.82,83  
 
 
It was necessary for the reaction to be carried out in a dry solvent (i.e. dry THF) and 
under an atmosphere of argon to remove the presence of water in the reaction mixture 
from solvent and atmosphere until the hydrolysis stage. These steps were undertaken 
as TBAF reacts with water to form hydrofluoric acid (HF).  
To separate out the product and starting materials, in this case, we added a saturated 
solution of sodium hydrogen sulfite dissolved in water. This causes the aldehyde starting 
material to hydrolyse and move it into the aqueous phase while leaving only the product 
in the organic phase. The reaction of benzaldehyde gave a yield of 70 % when the 
reaction was carried out in dry conditions and scaled up from 30 mmol to 60 mmol.  
The reaction proceeds via an F- attack on TMSCF3 to form the CF3 anion before it can 
attack the electron-deficient carbon in the aldehyde. Next the resulting oxide is thought 
to propagate the reaction via reacting with TMSCF3, which will then attack another 







Figure 63- Mechanism for the addition of CF3 to a carbonyl via TMSCF341 
Figure 62- Reaction of benzaldehyde with TMSCF3 
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With our general process for synthesis of trifluoromethyl alcohols established (fig. 
64), the reaction was expanded to a range of substituents bearing different electron 
donating and electron withdrawing groups as listed in Table 1. It would be expected that 
an increased yield would be observed for an electron withdrawing group because it 
causes the aldehyde to be become more activated towards nucleophilic reagents. 
However, there was not much difference observed between the yields of electron 
withdrawing groups compared to electron donating groups shown below. 
 
 

















Compounds 2 were characterized by NMR spectroscopy and GC-MS analysis. The 
obtained data was consistent with literature data. NMR spectroscopic data for 2a are 
discussed here and all other data for 2 followed similar patterns.  
All the ArCHOHCF3 compounds gave only one peak in the 19F NMR spectrum (fig. 65). 
This chemical shift was a unique doublet (3JFH 6.6 Hz) for each compound dependent on 
the side group, δF = -78.4 ppm for 2a. An upfield chemical shift between 0.05-0.65 ppm 





























In the 1H NMR spectrum of 2a the most important peak is for CH(OH) which is a 
quartet (3JHF 6.6 Hz) at 5.02 ppm because it has been split by the adjacent CF3 group (fig. 
66). This was backed up by the appearance of a broad singlet at 2.74 ppm for the alcohol 
proton. In the 13C NMR spectrum of 2a the two non-aromatic carbon peaks are quartets 
and, to differentiate between them, the CF3 carbon at 124.4 ppm has a 1JCF coupling 










Figure 66- 1H NMR spectrum for compound 2a in CDCl3 on a 400 MHz spectrometer 
2a 
d, 3JFH 6.6 Hz 
CH(OH), q, 3JHF 6.6 Hz 
OH 













Gas chromatography-mass spectrometry was also used, alongside these NMR 
spectral analysis to prove that all compounds mentioned above were formed. The 
molecular ion for compound 2a at m/z = 176.1 was observed for the component at a 
retention time of 3 mins. The main fragment ion for compounds 2 was [M-CF3]+. 
Crystals of 2d were formed via recrystallization from chloroform followed by slow 
evaporation in a solution of acetone. Compound 2d then had its structure determined 




















CF3, q, 1JCF 282 Hz 
CHOH, q, 2JCF 32 Hz 
Figure 68- Molecular structure of compound 2d 











Compound 2d has a monoclinic crystal structure in space group P21/c. The crystal 
structure is constructed of hydrogen bonding between O-H…O-N and π-π interactions 
into double chains. Alongside this, π-π aromatic stacking is observed.  
This crystal structure is consistent with the structure of 2d. We also measured the 
crystal structures for compounds 2j (2-bromopyridyl) and 2n (napthyl) where the only 
major difference was for the hydrogen bonding sites. So, for the side groups that do not 
contain oxygen or nitrogen, the hydrogen bonding would be between O-H…O. This 
means that the space group changes to P-1 and the crystal of 2n is now triclinic in 
structure. It can be concluded from the crystal of 2j that the pyridyl equivalents have 
hydrogen bonding between OH…N. Just like with crystal 2d, the space group was P21/c 
and the crystal was monoclinic. The experimental data from this X-ray crystallography is 
shown appendix 1. 
2.2.2 Synthesis of ArCFHCF3 derivatives from ArCHOHCF3 
Once the trifluoromethyl-substituted alcohol 2 had been formed, the hydroxy group 
was replaced by a fluorine atom via reaction with DAST. To this end compound 2a was 
dissolved in DCM at 0 oC before the slow addition of DAST to the reaction mixture, which 
was then warmed to room temperature and stirred for 48 hours to give 1-phenyl-
1,2,2,2-tetrafluoroethane, 3a after work up (fig. 70). 
 






DAST is a potentially dangerous reagent so it must be added when the reaction 
mixture has been cooled by an ice bath. If we carried out reactions at 90 oC, DAST can 
react itself to form bis(dimethylamino)sulphur difluoride which is quite explosive. To 
further increase safe use, DAST was dissolved in 10 mL of DCM (over a spill tray) so that 
it was diluted if it got spilled.  
The reaction between an alcohol group and DAST starts via the oxygen attacking the 
sulfur and producing a fluoride ion which can attack the carbon to remove the oxygen 
and form the tetrafluoro product (fig. 71). It is reported that there is an inversion of the 
stereochemistry as the rate determining step goes via an SN2 pathway.84  
 
 
With conditions for the formation of 3a established, DAST reactions with 2a-k, l & n 
were carried out to form a family of ArCFHCF3 derivatives as shown below in table 2. 







Figure 70- Reaction scheme for compounds 2a-l with DAST 
3a, 75 % 
Figure 71- Mechanism for DAST reacting with an alcohol84 
33 
 
Table 2- Synthesis of ArCFHCF3 derivatives 
Compounds 3 were characterized by NMR spectroscopy and GC-MS analysis could be 
assigned. NMR spectral data for 3a are discussed here and all other data for 3 followed 





















increased yield because the alcohol would have been slightly activated for nucleophilic 
attack, but not much difference was observed in the yield.  
All compounds 3 gave two characteristic peaks in their 19F NMR spectra. For 
compound 3a, there was a doublet of doublets for CF3 (3JFF 12.9 Hz, 3JFH 6.2 Hz) at δ = -
78.8 and a doublet of quartets for CFH (2JFH 44.1 Hz, 3JFF 12.9 Hz) at δ = -194.6 (fig. 72). 
These shifts were unique for each side group derivative, with a shift range of 0.2 ppm 
and 0.1 ppm for the doublet of doublets, and a shift range of 3.5 ppm and 4 ppm for the 








The 1H and 13C NMR spectra were consistent with the formation of 3a. In the 1H 
spectrum the most important peak was for the CHF moiety which is now a doublet of 
quartets (2JHF 44.1 Hz, 3JHF 6.2 Hz) at 5.60 ppm (fig. 73). In the 13C spectrum of 3a the two 
non-aromatic carbon peaks are in similar positions as they were previously in the alcohol 
(fig. 74). However, the CFH carbon at 89.1 ppm is now a doublet of quartets (1JCF 186 Hz, 
2JCF 35 Hz) whereas the CF3 carbon at 122.4 is now a quartet of doublets (1JCF 281 Hz, 2JCF 





Figure 72- 19F NMR spectrum of compound 3a in CDCl3 on 400 MHz spectrometer 
dd, 3JFH 12.9 Hz, 3JFH 6.2 Hz 

















For compounds 3d, 3i and 3j, high-resolution mass spectrometry was used to confirm 
their composition. The molecular ion for compound 3a at m/z = 178.0 at a retention 
time of 2.01 mins and the main fragment ion for compounds 3 was [M-CF3]+. 
2.2.3 Conformation of –CFHCF3 units 
In the following section, the conformation of the Ar-CHFCF3 unit will be discussed and 
in particular, if the functional group lies in or out of the aromatic ring plane. The dihedral 
angle between the aromatic ring and the benzylic CF bond was required to find out the 
preferred conformation of the functional group via a rotational energy profile. This is 
important because it can give an indication of the intra- and intermolecular forces within 
a molecule.  





Figure 74- 13C NMR spectrum of compound 3a in CDCl3 on a 101 MHz spectrometer 
CHF, dq, 2JHF 44.1 Hz, 3JHF 6.2 Hz 
CF3, qd, 1JCF 281 Hz, 2JCF 29 Hz 
 










The purpose of the first set of calculations was to see how the benzylic CF sits in 
relation to the aromatic ring for the –CFHCF3 functional group. The CFHCF3 functional 
group was to be compared to three other related functional groups (-OCF3, OCH3 and –
CFHCH3) all of which have known conformations when directly bonded to an aromatic 
ring. The rotational energy profiles of the four functional groups were calculated 








We thank Dr. Mark Fox, Durham University, for carrying out these calculations. 
Through these calculations it was found that the optimum conformation of the (H)C-F 
bond is perpendicular to the ring plane. The following graph shows the difference 
between carbon and oxygen being the connecting atom between the phenyl ring and 
the functional group (fig. 81). The other comparison is between a methyl and a 
trifluoromethyl functional groups. 




The –OCH3 side group is unusual because, unlike –CHFCF3, -CHFCH3 and –OCF3, the 
methyl group of OCH3 prefers to be in the same plane as the aromatic ring. This is shown 
by the graph above, where the energy maxima are at 90 o and 270 o for –OCH3 whereas 
these angles are the relative energy minima (optimal conformation) for the other three 
side groups including –CHFCF3. This is because one the lone pairs on the oxygen will be 
perpendicular to the ring plane to participate in resonance structures. The most 
interesting side group is –OCF3 because there are small maxima at 90 o and 270 o so the 
CF3 group cannot be fully perpendicular to the ring plane. This is to limit electronic 
repulsions between the oxygen pairs and the aromatic nucleus. Hence, the non-bonding 
oxygen lone pairs and the aromatic nucleus are not conjugated.53 Further to this the –
OCF3 side group, surprisingly, has a very small rotational energy barrier. This means 
there are relatively small energy maxima compared to the other side groups preventing 
the lone pairs from being perpendicular to the ring plane. Thus, the fluorine atoms in 
the trifluoromethyl group are further away from the delocalised π electrons to minimise 
electrostatic repulsions. There is little difference between the relative energy/ dihedral 
angle of CHFCF3 and CHFCH3. The CF3 group causes a small decrease in rotational energy 
barrier and a small change in optimal dihedral angle (relative to CH3) because of a minor 





























Figure 81- Varying dihedral angle to find optimal conformations of ArX-Y  
X = C or O 
Y = F or CF3 or CH3 
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The second set of calculations was done to test the rotational energy of the ArC-CF3 
bond. for  –CH2CH3, CH2CF3 and –CF2CF3 functional groups bonded to an aromatic ring 
and to assess whether the CF3/ CH3 group would prefer to be in or out of the aromatic 
ring plane. The calculation was also done on the dihedral angle between the functional 
group and the aromatic ring, but this time based the alkyl chain rather than the benzylic 




The graph above indicates that both the CF3 and CH3 groups prefer to be orthogonal 
to the aromatic ring plane. The CH3 containing functional group had the smallest 
rotational energy barrier preventing it from rotating into the aromatic ring plane. This is 
due to the CF3 being a larger group than CH3 (increased steric repulsion) and an increase 
in electronic repulsion between the CF3 group and the aromatic ring. It was also 
observed that the benzylic CH2 group caused a lower rotational energy barrier compared 





























Figure 83- Varying the dihedral angle to see how Ar-CCF3/ CH3 is affected 
X = CH2 or CF2 
Y = CF3 or CH3 
Figure 82- Dihedral angle used to determine relative conformation preferences 
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electronic and steric repulsion (same reasons as for CF3 group) when in the plane of the 
aromatic ring. This means that the CH2 containing functional groups would have more 
freedom to rotate, as there would be hardly any electronic repulsion in comparison.  
2.2.4.1 Nitration of Ar-CHFCF3 (3a) by NO2BF4 
We next studied how CFHCF3 substituents affected electrophilic substitution 
processes in comparison with CF3 and OCF3 derivatives. There are several ways to add a 
nitro group to an aromatic ring such as a mix of concentrated nitric and sulfuric acids,85 
nitryl chloride with a catalyst of titanium tetrachloride86/ boron trifluoride86 or silver 
nitrate with boron trifluoride as a catalyst.87 For mono substitution reactions carried out 
on phenyl rings the simplest reagent to use is nitronium tetrafluoroborate.88 This is 
because under standard laboratory conditions (room temperature and pressure) 
nitration reactions are relatively selective. 
First nitronium tetrafluoroborate was dissolved in nitromethane at 0 oC under an 
atmosphere of argon. Next, compound 3a was dissolved in nitromethane before being 
added dropwise to the nitronium tetrafluoroborate. The reaction was then stirred 
continually at room temperature for 4 days to give 1-(3-nitrophenyl)-1,2,2,2-
tetrafluoroethane, 5a in a good yield. Both CF3 and OCF3 derivatives substitute at the 







From previous research,88 the most suitable solvents for NO2BF4 nitration are 
nitromethane or sulfolane. However, the main problem with sulfolane is that its melting 
point (25 oC) is near room temperature so it would have required vigorous stirring to 
constantly keep it in a liquid state before either of the reagents could be added. So, 
nitromethane is the more convenient solvent.  
Figure 83- Reactions of CF3 substituted phenyl derivates with NO2BF4 
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The 1H, 13C and 19F NMR spectra of compound 5a all indicated that the compound 3a 
had been nitrated. Gas chromatography-mass spectroscopy showed that the reaction 
had only proceeded to mono substitution. The molecular ion for compound 5a at m/z = 
223.1 was at a retention time of 3.27 mins. The main fragment ion for compound 5a was 
[M-CF3]+.  
The most useful spectrum for determining the position of substitution of the nitro 
group on compound 5a was the 1H NMR spectrum. In the 1H spectrum, there was a 
double of quartets (2JHF 44.1 Hz, 3JHF 5.9 Hz) at 5.74 ppm for the CFH resonance (fig. 84). 
The remaining four peaks were in the aromatic region indicating that substitution was 
either in the ortho or meta position because the previous synthesized para nitro 
equivalent (3d) only had two aromatic proton resonances. For ortho substitution, it was 
expected that the splitting of the four peaks would be three doublet of doublet of 
doublets and one doublet of doublets. For meta substitution, it was expected that there 
would be one doublet, two doublet of doublets and one doublet of doublet of doublets. 
The splitting pattern of 5a was consistent with meta substitution. The CHCCFH (Hc) 
resonance was a doublet of doublet of doublets (4JHF 8.8 Hz, 3JHH 7.7 Hz, 4JHH 1.4 Hz) at 
7.69 ppm. The next peak was doublet of doublet (3JHH 7.7, 3JHH 2.0 Hz) at 7.82 ppm for 
the CHCHCCFH (Hb). The following peak was a doublet (4JHF 8.1 Hz) at 8.33 ppm for the 
O2NCHCCFH (Hd). The final aromatic proton was the CHCNO2 (Ha) resonance at 8.36 ppm 








The 19F and 13C NMR spectra from a reaction between compound 3a and nitronium 
tetrafluoroborate were consistent with the formation of 5a. In the 19F NMR spectrum 




CFHCF3, dq, 2JHF 44.1 Hz, 
3JHF 5.9 Hz 
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there were two peaks (fig. 85). The first peak was a doublet of doublets (3JFF 12.8 Hz, 3JFH 
5.9 Hz) at -78.7 ppm for the CF3 group. The final peak was a doublet of quartets (2JFH 44.1 
Hz, 3JFF 12.8 Hz) at -196.5 ppm for the CFH resonance. In the 13C NMR, the two non-
aromatic carbons are a doublet of quartets (1JCF 189 Hz, 2JCF 36 Hz) at 87.9 ppm for the 
CFH carbon and a quartet of doublets (1JCF 282 Hz, 2JCF 28 Hz) at 121.8 ppm for the CF3 
carbon (fig. 86). 13C DEPT was used first alongside their J coupling values to determine 
the CNO2 carbon (C2) and CCFH carbon (C6). The CCFH resonance was a doublet (2JCF 8 
Hz) at 122.3 ppm. Then the CNO2 resonance is a doublet (4JCF 1 Hz) at 125.4 ppm. Next 
the CHCCFH carbon (C5) and the O2NCHCCFH carbon (C1) can be assigned because they 
are both doublets and that C1 was further de-shielded as it is closer to the nitro group. 
The C5 resonance was a doublet (3JCF 7 Hz) at 128.2 ppm. Then the C1 resonance was a 
doublet (3JCF 7 Hz) at 132.9 ppm. The final two aromatic carbons were both singlets and 
were assigned as the CHCNO2 carbon (C3) was closer to the nitro group so was further 
de-shielded. The CHC(H)CNO2 carbon (C4) resonance was a singlet at 124.0 ppm. Finally, 
























This electrophilic nitration mainly occurs at the meta site on the phenyl ring because 
the functional group (CFHCF3) is electron withdrawing (fig. 87). However, as seen above 
in figure 86, the reaction was left too long so a small amount of dinitro substituted 




Nitration of 3a as the substrate was used to assess the effect of the CFHCF3 functional group 
on the SEAr process. 5o and 5p were synthesised to see how the nitrating agent reacted 
with on similar aromatic compounds with fluorine-containing side groups. Compounds 
5o and 5p were formed in high yield. Similarly, compound 5o was assigned as meta 
substitution from the 1H NMR which matched the literature data91 for the formation of 
3-nitro-α,α,α-trifluorotoluene. Compound 5p was also assigned as meta substitution by 
comparison to literature data.92 
2.2.4.2 Competitive nitration kinetics between ArCFHCF3, ArOCF3 and ArCF3 
In the previous section we proved that the ArCFHCF3 functional group is electron 
withdrawing by its meta substitution just like ArOCF3 and ArCF3. To study the ArCFHCF3 
functional group’s relative rate of reactivity we carried out a competitive kinetic 
nitration reaction. To do this 0.055 mmol of nitronium tetrafluoroborate was dissolved 
C6 
Figure 87- Mechanism for reactions between NO2BF4 and alkoxy/ alkyl fluoride substituted aromatics 









CFH, dq, 1JCF 189 Hz, 2JCF 
36 Hz 
CF3, qd, 1JCF 282 Hz, 





in 0.65 ml of nitromethane. Then the resulting solution was transferred to an NMR tube 
along with a D2O lock tube. Next 0.056 mmol of each of the substrates (1-phenyl-1,2,2,2-
tetrafluoroethane 3a, trifluoromethoxy benzene 3p and α,α,α-trifluorotoluene 3o) was 
added to the NMR tube as a liquid. The reaction was then monitored by 19F NMR at fairly 
regular intervals.  
The reaction was monitored over a 24-hour period. Monitoring was possible by 19F 
NMR spectroscopy because the addition of a nitro group caused a change in the shift for 
the CF3 group in the range 0.1 – 0.15 ppm for each molecule. This change was observable 
in the NMR spectrum. The ArOCF3 functional group reacted fastest and showed the 
greatest conversion. This means that it was the least electron withdrawing functional 
group and hence had the most activated phenyl ring. The next fastest functional group 
was ArCF3 which was indicated from NMR spectra. From the data collected, it was about 
0.9 times less reactive than ArOCF3. The slowest reacting was the ArCFHCF3 which was 
roughly 0.5 times less reactive than the ArCF3 system.  
2.2.5 Synthesis of ArCHOHCF2CF3 derivatives 
Addition of a CF2CF3 functional group to organic molecules can be done via 
compounds such as LiCF2CF3, ICF2CF3 or CuCF2CF3 as mentioned in section 1.5. For the 
reactions carried out on aryl aldehydes the best reagent to use is TMSCF2CF3. First 
benzaldehyde and TMSCF2CF3 were dissolved in dry THF at 0 oC under an atmosphere of 
argon before the addition of the catalytic tetra-n-butylammonium fluoride (TBAF). The 
reaction was stirred continually while it was warmed to room temperature over the 
following 3 hours. The resulting benzyl-trimethylsilyl ether was hydrolysed by the 
addition of 6M hydrochloric acid and then the reaction mixture was allowed to stir for 





 Figure 88- Reaction of aryl aldehydes derivatives and TMSCF2CF3 
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When switching substrates from phenyl to pyridine derivatives, it seems that the 
aldehyde became less susceptible to nucleophilic attack. The pyridine substrate under 
similar conditions (only 1.5 equivalents TBAF) to the TMSCF3 reaction gave less than half 
of the TMSCF3 reaction yield (51 %) since TMSCF2CF3 is a weaker nucleophile compared 
to TMSCF3.  
For compound 2k three peaks in the 19F NMR spectrum were observed (fig. 89). First 
a singlet at δ = -81.3 for the CF3 group. The final two peaks were a doublet of doublets 
at δ = -121.9 (2JFF 275.8 Hz, 3JFH 7.3 Hz) and -129.4 (2JFF 275.8 Hz, 2JFH 16.7 Hz) for the CF2 
fluorine atoms because they are diasterotopic. The two fluorines are differentiated by 
their J coupling value to the proton on the adjacent carbon atom. The fluorine which 
closer in space to that proton will have a higher splitting value. 
Pyridine derivatives were identified by having similar shifts. The first doublet of 
doublets was shifted upfield by about 1.4 ppm because of the deshielding caused by the 
pyridine ring whereas the second doublet of doublets showed little change when going 







The 1H and 13C NMR spectra were consistent with the formation of 2k. In the 1H 
spectrum the most diagnostic peak is for CH(OH) which is a doublet of doublets (3JHF 16.7 
Hz, 3JHF 7.3 Hz) at 5.12 ppm because it has been split by the CF2 group showing that the 
product had been formed (fig. 90). The formation of 2k was backed up by the 
appearance of a broad singlet at 2.61 ppm for the alcohol proton. In the 13C NMR 
F1 
F2 




spectrum, the three non-aromatic carbon peaks are doublet of doublets, doublet of 
doublet of quartets and quartet of triplets (fig. 91). The CF3 carbon is a quartet of triplets 
(1JCF 287 Hz, 2JCF 36 Hz) at 119.3 ppm, the CF2 carbon is a doublet of doublet of quartets 
(1JCF 261 Hz, 1JCF 255 Hz, 2JCF 36 Hz) at 113.2 ppm and the CHOH resonance is a doublet 
of doublets (2JCF 28 Hz, 2JCF 22 Hz) at 72.1 ppm. 13C DEPT was used to determine the 
singlet aromatic ipso carbon at 134.2 ppm because it was the only aromatic carbon not 
bonded to a hydrogen atom. Next the singlet para carbon was determined to be at 129.7 
ppm as it is the smallest of three remaining peaks. The remaining two peaks are assigned 
as a broad singlet at 128.0 ppm for the ortho carbons (peak is broad because of a small 













Figure 90- 1H NMR for compound 2k in CDCl3 on a 400 MHz spectrometer 












Gas chromatography-mass spectrometry was also used, alongside these NMR 
spectra, to prove that all compounds mentioned above were formed. The molecular ion 
for compound 2m at m/z = 226.1 at a retention time of 2.91 mins. The main fragment 
ion for compounds 2 was [M-CF2CF3]+.  
Crystals of 2m were formed via recrystallization in a mixture of hexane/ acetone 
followed by a slow evaporation in a mixture of hexane/ DCM. Compound 2m then had 
its structure determined by x-ray crystallography (fig. 92&93). Again, we thank Dr. 








Figure 92- Molecular structure for compound 2m 
Figure 91- 13C NMR for compound 2k in CDCl3 on a 101 MHz spectrometer 
CF3, qt, 1JCF 282 Hz, 
    2JCF 36 Hz 
 
CHOH, dd, 








CF2, ddq, 1JCF 261 Hz, 









2m has a monoclinic crystal in the space group P21/n. and is constructed of hydrogen 
bonding between O-H…N and π-π interactions into double chains. Alongside this, π-π 
aromatic stacking is observed. The experimental data from this X-ray crystallography is 
shown in appendix 2. 
2.2.6 Synthesis of ArCFHCF2CF3 derivatives 
Once the pentafluoroethyl substituted alcohol is formed, the hydroxy group can be 
replaced by a fluorine atom via a reaction with DAST using methodology described in 
section 2.2.2. Compound 2k was dissolved in DCM at 0 oC before the slow addition of 
DAST to the reaction mixture after which the reaction warmed to room temperature 






For compound 3k four peaks were observed in the 19F NMR (fig. 95). The first peak 
was a doublet of doublets (3JFF 11.1 Hz, 3JFH 2.2 Hz) at -82.2 ppm for the CF3 group. Then 
Figure 93- Compound 2m unit cell 
Figure 94- Reaction scheme for compounds 3k&m with DAST 
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the next two peaks are a doublet of doublet of doublets at -122.9 ppm (2JFF 283.9 Hz, 3JFF 
11.1 Hz, 3JFH 4.3 Hz) and -131.6 ppm (2JFF 283.9 Hz, 3JFH 17.5 Hz, 3JFF 15.1 Hz) for the CF2 
fluorine atoms because they are diasterotopic. As with the alcohol precursor, the two 
fluorines are differentiated by their J coupling values with either the fluorine or the 
proton on the adjacent carbon atom. The fluorine which is closer in space to both the 
fluorine and the proton will have a higher splitting value from both. The final peak was 
a doublet of doublet of pentuplets (2JFH 43.8 Hz, 3JFF 15.1 Hz, 3/4JFF 11.1 Hz) at -195.7 ppm 
for the CFH resonance. For 3m, we observed a similar spectrum, but the CF2 and CF3 
resonances were slightly shifted upfield (0.1 – 0.25 ppm) whereas the CFH resonance 
was shifted downfield by 2.8 ppm.  
  
The 1H and 13C NMR spectra were consistent with the formation of 3k. In the 1H 
spectrum the most important peak is for CHF which is a doublet of doublet of doublets 
(2JHF 43.8 Hz, 3JHF 17.5 Hz, 3JHF 4.3 Hz) at 5.73 ppm because it is split by the CF2 group and 
now by the CFH fluorine atom (fig. 96). In the 13C spectrum, the three non-aromatic 
carbon peaks are in similar positions as they were previously in the alcohol 2k (fig. 97). 
The CF3 carbon is now a quartet of triplet of doublets (1JCF 288 Hz, 2JCF 36 Hz, 3JCF 2 Hz) at 
119.2 ppm. Next the CF2 carbon is now a doublet of doublet of doublet of quartets (1JCF 
263 Hz, 1JCF 254 Hz, 2JCF 37 Hz, 2JCF 29 Hz) at 111.5 ppm. The CFH resonance was a doublet 
of doublet of doublets (1JCF 186 Hz, 2JCF 32 Hz, 2JCF 24 Hz) at 88.4 ppm. 13C DEPT was used 
assign the doublet (2JCF 20 Hz) ipso aromatic carbon at 129.8 ppm because it was the 




Figure 95- 19F NMR of compound 3k in CDCl3 on a 400 MHz spectrometer 
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carbons are determined to be doublets and assigned based on their J coupling value. 
The ortho carbons were a doublet (3JCF 7 Hz) at 127.7 ppm and the meta carbons were a 
doublet (4JCF 2 Hz) at 130.7 ppm. Then the remaining unassigned peak was a singlet for 


















The molecular ion for compound 3k at m/z = 228.0 was at a retention time of 2.15 
mins in GC/ MS. The main fragment ion for compounds 3 was [M-CF2CF3]+.  
 
Figure 97- 13C NMR of compound 3k in CDCl3 on a 101 MHz spectrometer 
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CF3, qtd, 1JCF 288 Hz, 
2JCF 36 Hz, 3JCF 2 Hz 
 
CF2, dddq, 1JCF 263 Hz, 
1JCF 254 Hz, 2JCF 37 Hz, 




2.2.7 Formation of ArCFC=CFCF3 derivatives 
An alkene substituted with both an aromatic group and trifluoromethyl functional 
group can be made by reacting the hexafluoro aromatic compound 3k with a strong 
base, such as KOtBu. First 1,2,2,3,3,3-hexafluoro-1-phenylpropane was dissolved in dry 
THF at 0 oC and under an atmosphere of argon before the addition of KOtBu. The reaction 
was then stirred continually while warmed to room temperature for t two hours to give 





It was necessary for the reaction to be done in a dry solvent (i.e. dry THF) and under 
an atmosphere of argon to remove the presence of water in the reaction mixture from 
solvent and atmosphere.  
The elimination reaction of 3k and 3m occurs either as an E1CB or a concerted E2 










Figure 99- E2 elimination pathway 
Figure 98 Reaction of potassium butoxide and -CFHCF2CF3 compounds 3k and 3m 
Figure 100- E1CB elimination pathway 
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Both of compounds 4k and 4m showed three peaks in their 19F NMR. For compound 
4k, there was a doublet of doublets (3JFF 22.0 Hz, 4JFF 10.6 Hz) at –67.0 ppm for the CF3 
group. Both of the fluorines directly bonded to the double bond showed a splitting 
pattern of a doublet of quartets and could be differentiated by their J coupling values. 
The CFCF3 resonance was a doublet of quartets (3JFF 131.7 Hz, 4JFF 22.0 Hz) at -146.3 ppm. 
Then the CFPh resonance was a doublet of quartets (3JFF 131.7 Hz, 4JFF 10.6 Hz) at -169.5 









The 1H and 13C NMR spectra were consistent with the formation of 4k. The only peaks 
observed on the 1H NMR spectrum were for the aromatic protons indicating that the 
CFH proton was lost in the reaction and the reaction went to completion (fig. 102). For 
the 13C NMR spectrum, the three non-aromatic carbons have characteristic shifts (fig. 
103). The CF3 carbon is now a quartet of doublet of doublets (1JCF 272 Hz, 2JCF 36 Hz, 3JCF 
4 Hz) at 119.5 ppm. Next the CFCF3 carbon is a doublet of doublet of quartets (1JCF 249 
Hz, 2JCF 51 Hz, 2JCF 40 Hz) at 138.4 ppm. Finally, the CFPh resonance is a doublet of 
doublet of quartets (1JCF 250 Hz, 2JCF 36 Hz, 3JCF 3 Hz) at 151.4 ppm. The alkene carbon 
resonances could be differentiated by their J coupling values. The ipso carbon is a 
doublet of doublets (2JCF 24 Hz, 3JCF 6 Hz) at 127.2 ppm. Next the ortho carbons were a 
doublet (3JCF 8 Hz) at 126.6 ppm. The meta carbons are also a doublet (4JCF 2 Hz) at 128.9 
ppm. Finally, the para carbon resonance appears as a doublet (4JCF 2 Hz) at 131.3 ppm.  
 
























Gas chromatography-mass spectrometry was also used, alongside these NMR 
spectra, to prove that all compounds mentioned above were formed. The molecular ion 
for compound 4k at m/z = 208.0 at a retention time of 2.34 mins. The main fragment ion 
for compounds 4 was [M-CF3+F]+.  
Figure 102 1H NMR for compound 4k in CDCl3 on a 400 MHz spectrometer 
Figure 103- 13C NMR for compound 4k in CDCl3 on a 101 MHz spectrometer 
CF3, qdd, 1JCF 272 Hz, 
2JCF 36 Hz, 3JCF 4 Hz 
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We have developed methodology for the synthesis of ArCHFCF3 derivatives by a two-





A ray of systems bearing substituents have been prepared for the first time and 
characterized by NMR, mass spec. and x-ray crystallography. 
Overall all compounds have been made in good yield and confirmed by assigning the 
data from GC-MS, crystal structures and 1H, 13C and 19F NMR spectra. Within this thesis 
we have shown that the ArCFHCF3 functional group can be synthesized by the pathway 
set out in section 2.1. The first part of the pathway (TMSCF3 and TBAF) worked in a good 
yield for all alcohols irrelevant of the substituent on the aromatic ring.  
The DAST stage (Fig. 104) on average gave slightly lower yields than the first stage. 
Nevertheless, the ArCFHCF3 analogues were produced in good yield and only formed the 
desired product. An unforeseen problem was that compounds 3a, 3f and 3k 
decomposed upon heating on the high vacuum line. We have shown that the most likely 
decomposition pathway gives an ether. Furthermore, we have shown how to avoid this 
unexpected decomposition occurring upon workup.  
We next studied the reaction of ArCFHCF3 derivatives with an electrophile such as 
nitronium tetrafluoroborate. As expected the ArCFHCF3 functional group was electron 
withdrawing and, hence, activating the aromatic ring to electrophilic substitution in the 
meta position. Competition reactions of ArCFHCF3 with trifluoromethoxy benzene and 
α,α,α-trifluorotoluene. A competitive NMR experiment was carried out to see which of 
the functional groups was most reactive and the -CFHCF3 functional group was less 
reactive than CF3 and OCF3. 
1-(3-Pyridyl)-1,2,3,3,3-pentafluoroprop-1-ene was synthesized by a reaction 
between the prior hexafluoro compound and a base, KOtBu. 
Figure 104- Two step reaction scheme for the formation of the ArCHFCF3 functional group 
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Chapter 3: Experimental 
3.1 General 
Anhydrous solvents were purchased from Acros Organics and stored over 3Å molecular 
sieves under an argon atmosphere. Unless otherwise stated, all other chemicals were 
purchased from Fisher Scientific, Fluorochem or Sigma Aldrich and were used without 
any further purification. Thin layer chromatography was carried out using Macherey-
Nagel™ standard SIL G silica layers (5-17 μm with fluorescence indicator UV254, 
compounds visualised under UV light) on Polygram™ polyester sheets purchased from 
Fisher Scientific and column chromatography using silica gel LC401 (40-63 μm) 
purchased from Fluorochem. Proton, carbon and fluorine nuclear magnetic resonance 
(NMR) spectra were recorded on a Bruker 400 Ultrashield (1H NMR at 400 MHz; 13C NMR 
at 101 MHz; 19F NMR at 376 MHz) spectrometer with residual solvent peaks as the 
internal standard (1H NMR, CHCl3 at 7.26 ppm; 13C NMR, CDCl3 at 77.16 ppm) or relative 
to an external standard (19F NMR, CFCl3 at 0.00 ppm). NMR spectroscopic data are 
reported as follows: chemical shift (ppm), integration, multiplicity (s=singlet, d=doublet, 
t=triplet, q=quartet, p=pentet, m=multiplet), coupling constant(s) (Hz), assignment. 
NMR assignments were made using COSY, DEPT-135, HSQC and HMBC experiments. Low 
resolution LC-MS data was recorded on a Waters Ltd TQD mass spectrometer equipped 
with Acquity UPLC. GC-MS data was recorded on a Shimadzu QP2010-Ultra. Accurate 
mass analysis was achieved with a Waters Ltd QtoF Premier mass spectrometer 
equipped with an accurate solids analysis probe (ASAP) or a Waters Ltd LCT Premier XE 
mass spectrometer equipped with Acquity UPLC and ASAP. Infra-red (IR) spectra were 
recorded on a Perkin Elmer FTIR Spectrum Two fitted with an ATR probe and selected 
absorption maxima are reported in wavenumbers. Melting points were measured with 
a manually operated Gallenkamp apparatus in open capillary tubes at atmospheric 







3.2 Synthesis of 1-phenyl-1,2,2,2-trifluoroethanol derivatives: 
General Procedure – Trifluoromethylation using Ruppert’s reagent (2a-j, 
l). Aldehyde derivative 1 (30 mmol) and CF3SiMe3 (5.1 g, 5.4 mL, 36 mmol) were 
dissolved in THF (30 mL) at 0oC under an atmosphere of argon. TBAF (0.1 g) was added 
and the reaction was allowed to warm to RT and stirred for 2 h. 6 M HCl (6 mL) was 
added and the mixture stirred for 48 h. The reaction mixture was extracted with ether 
(3 x 30 mL), washed with water (2 x 50 mL) and brine (50 mL), dried (MgSO4) and the 




1-Phenyl-2,2,2-trifluoroethanol (2a). Benzaldehyde, 1a, (3.2 g, 30 mmol) and TMSCF3 
(5.1 g, 36 mmol) gave 1-phenyl-2,2,2-trifluoroethanol, 2a, (4.12 g, 78 %) as clear, yellow 
liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.51 – 7.45 (2H, m, Ar-Hb), 7.44 – 7.40 (3H, 
m, Ar-Ha), 5.02 (1H, q, 3JHF 6.6, Hc), 2.74 (1H, s, OH). 19F NMR (376 MHz, Chloroform-d) δ 
-78.4 (d, 3JFH 6.6, CF3). 13C NMR (101 MHz, Chloroform-d) δ 134.1 (s, Ar-C4), 129.7 (s, Ar-
C1), 128.8 (s, Ar-C3), 127.6 (s, Ar-C2), 124.4 (q, 1JCF 282, C6), 73.0 (q, 2JCF 32, C5). GC-MS: 
3.0 mins, m/z = 176.1 (65 %, [M]+ ), 159.1 (1, [M-F]+), 107.1 (100, [M – CF3]+), 79.1 (96, 




1-(4-Bromophenyl)-2,2,2-trifluoroethanol (2a). 4-Bromobenzaldehyde, 1b, (4.28 g, 
30.6 mmol) and CF3SiMe3 (5.1 g, 36 mmol) gave 1-(4-bromophenyl)-2,2,2-
trifluorethanol, 2b, (2.10 g, 36 %) as a clear, pale orange liquid.  1H NMR (400 MHz, 
Chloroform-d) δ 7.54 (2H, d, 3JHH 8.1, Ar-Ha), 7.35 (2H, d, 3JHH 8.1, Ar-Hb), 5.00 (1H, q, 3JHF 
6.6, Hc) 2.87 (1H, s, OH). 19F NMR (376 MHz, Chloroform-d) δ -78.5 (d, 3JFH 6.6, CF3). 13C 
NMR (101 MHz, Chloroform-d) δ 132.0 (s, Ar-C4), 131.9 (s, Ar-C2), 129.2 (s, Ar-C3), 124.1 




























1-(4-Chlorophenyl)-2,2,2-trifluoroethanol (2c). 4-Chlorobenzaldehyde, 1c, (4.21 g, 29.9 
mmol) and CF3SiMe3 (5.1 g, 36 mmol) gave 1-(4-chlorophenyl)-2,2,2-trifluoroethanol, 2c, 
(5.36 g, 85 %) as an opaque, light orange liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.44 
– 7.40 (2H, m, Ar-Ha), 7.40 – 7.36 (2H, m, Ar-Hb), 4.99 (1H, q, 3JHF 6.6, Hc) 3.20 (1H, s, OH). 
19F NMR (376 MHz, Chloroform-d) δ -78.5 (d, 3JFH 6.6, CF3). 13C NMR (101 MHz, 
Chloroform-d) δ 135.6 (s, Ar-C1), 132.6 (s, Ar-C4), 129.0 (s, C2), 128.9 (s, C3), 124.2 (q, 
1JCF 282, Ar-C6), 72.2 (q, 2JCF 32, C5). GC-MS: 3.57 mins, m/z = 210.0 (55 %, [M]+ ), 141.2 




1-(4-Nitrophenyl)-2,2,2-trifluoroethanol (2d). 4-Nitrobenzaldehyde, 1d, (4.60 g, 30.5 
mmol) and CF3SiMe3 (5.1 g, 36 mmol) gave 1-(4-nitrophenyl)-2,2,2-trifluoroethanol, 2d, 
(2.10 g, 36 %) as a pale orange solid.  1H NMR (400 MHz, Chloroform-d) δ 8.19 (2H, d, 
3JHH 8.7, Ar-Ha), 7.66 (2H, d, 3JHH 8.7, Ar-Hb), 5.47 (1 H, s, OH), 5.12 (1H, q, 3JHF 6.5, Hc). 19F 
NMR (376 MHz, Chloroform-d) δ -78.1 (d, 3JFH 6.5, CF3). 13C NMR (101 MHz, Chloroform-
d) δ 148.4 (s, Ar-C1), 141.84 (s, Ar-C4), 128.6 (s, Ar-C2), 124.1 (q, 1JCF 283.0, Ar-C6), 123.5 
(s, Ar-C3), 71.4 (q, 2JCF 32, Ar-C5). GC-MS: 4.27 mins, m/z = 221.0 (12 %, [M]+ ), 152.1 (100, 


































1-(4-Methoxyphenyl)-2,2,2-trifluoroethanol (2e). 4-Methoxybenzaldehyde, 1e, (4.11 g, 
30.2 mmol) and CF3SiMe3 (5.1 g, 36 mmol) gave 1-(4-methoxyphenyl)-2,2,2-
trifluoroethanol, 2e, (5.20 g, 74 %) as a clear, dark orange liquid.  1H NMR (400 MHz, 
Chloroform-d) δ 7.38 (2H, d, 3JHH 9.0, Ar-Hb), 6.91 (2H, d, 3JHH 9.0, Ar-Hc), 4.91 (1H, q, 3JHF 
6.9, Hd), 4.07 (1H, s, OH), 3.80 (3H, s, Ha). 19F NMR (376 MHz, Chloroform-d) δ -78.6 (d, 
3JFH 6.9, CF3). 13C NMR (101 MHz, Chloroform-d) δ 160.6 (s, Ar-C2), 128.9 (s, Ar-C3), 126.4 
(s, Ar-C5), 124.5 (q, 1JCF 282, C7), 114.2 (s, Ar-C4), 72.6 (q, 2JCF 32, C6), 55.44 (s, C1). GC-
MS: 3.70 mins, m/z = 206.1 (83 %, [M]+ ), 137.3 (100, [M-CF3]+), 109.1 (22, [PhO(H)Me]+), 




4-(Fluorophenyl)-2,2,2-trifluoroethanol (2f). 4-Fluorobenzaldehyde, 1f, (3.82 g, 30.8 
mmol) and TMSCF3 (5.1 g, 36 mmol) gave 1-(4-fluorophenyl)-2,2,2-trifluoroethanol, 2f, 
(5.39 g, 90 %) as a translucent, yellow liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.47 
(2H, dd, 3JHH 8.9, 4JHF 5.2, Ar-Hb), 7.10 (2H, dd, 3JHH 8.9, 3JHF 8.7, Ar-Ha), 5.02 (1H, q, 3JHF 
6.6, Hc), 2.51 (1H, s, OH). 19F NMR (376 MHz, chloroform-d) δ -78.66 (3F, d, 3JFH 6.6, CF3), 
-111.81 (1F, tt, 3JFH 8.7, 4JFH 5.2, Ar-F). 13C NMR (101 MHz, chloroform-d) δ 163.5 (d, 1JCF 
284, Ar-C1), 129.9 (s, Ar-C4), 129.4 (d, 3JCF 9, Ar-C3), 124.3 (q, 1JCF 282, C6), 123.4 (d, 2JCF 
22.0, Ar-C2), 72.3 (q, 2JCF 32, C5). GC-MS: 3.84 mins, m/z = 194.0 (29 %, [M]+ ), 125.0 































1-(4-Trifluoromethylphenyl)-2,2,2-trifluoroethanol (2g). 4-Trifluoromethyl- 
benzaldehyde, 1g, (5.23 g, 30.1 mmol) and TMSCF3 (5.1 g, 36 mmol) gave 1-(4-
trifluoromethylphenyl)-2,2,2-trifluoroethanol, 2g, (4.93 g, 67 %) as a translucent, white 
liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.69 (2H, d, 3JHH 8.2, Ar-Ha), 7.63 (2H, d, 3JHH 
8.2, Ar-Hb), 5.07 (1H, q, 3JHF 6.5, Hc), 3.82 (1H, s, OH). 19F NMR (376 MHz, chloroform-d) 
δ -62.8 (3F, s, Ar-CF3), -78.4 (3F, d, 3JFH 6.5, CF3). 13C NMR (101 MHz, chloroform-d) δ 
138.1 (s, Ar-C5), 131.8 (q, 2JCF 32, Ar-C2), 128.0 (s, Ar-C4), 125.6 (q, 3JCF 4, Ar-C3), 124.2 
(q, 1JCF 284, C7), 124.0 (q, 1JCF 272, C1), 72.3 (q, 2JCF 32, C6). GC-MS: 3.05 mins, m/z = 
244.0 (15 %, [M]+ ), 175.0 (100, [M-CF3]+), 145.1 (21, [PhCF3-H]+), 127.1 (100, [PhCF2]+); 
as compared to literature data.82 
 
 
1-(4-Methylphenyl)-2,2,2-trifluoroethanol (2h). 4-Methylbenzaldehyde, 1h, (3.66 g, 
30.5 mmol) and TMSCF3 (5.2 g, 36.7 mmol) gave 1-(4-methylphenyl)-2,2,2-
trifluoroethanol, 2h, (2.14 g, 37 %) as a very pale, clear yellow liquid. 1H NMR (400 MHz, 
Chloroform-d) δ 7.36 (2H, d, 3JHH 7.8, Ar-Hb), 7.22 (2H, d, 3JHH 7.8, Ar-Hc), 4.99 (1H, q, 3JHF 
6.9, Hd), 2.57 (1H, s, OH), 2.38 (3H, s, Ha). 19F NMR (376 MHz, chloroform-d) δ -78.4 (d, 
3JFH 6.9, CF3). 13C NMR (101 MHz, chloroform-d) δ 139.7 (s, Ar-C5), 131.2 (s, Ar-C2), 129.5 
(s, Ar-C3), 127.5 (s, Ar-C4), 124.5 (q, 1JCF 282, C7), 72.9 (q, 2JCF 32, Ar-C6), 21.4 (s, C1). GC-
MS: 3.27 mins, m/z = 190.0 (50 %, [M]+ ), 121.1 (100, [M-CF3]+), 93.1 (77, [PhMe+H]+), 
91.1 (71, [PhCH2]+), 77 (39, [Ph]+); as compared to literature data.83 
 
 
 1-(3-pyridyl)-2,2,2-trifluoroethanol (2i). 3-Pyridinecarboxaldehyde, 1i, (3.19 g, 29.8 
mmol) and TMSCF3 (5.1 g, 36 mmol) gave 1-(3-pyridyl)-2,2,2-trifluoroethanol, 2i, (2.67 

































8.55 (1H, dd, 3JHH 4.7, 4JHH 2.2, Ha), 7.96 (1H, dd, 3JHH 8.0, 4JHH 2.2, Hc), 7.41 (1H, ddd, 3JHH 
8.0, 3JHH 4.7, 5JHH 0.8, Hb), 5.1 (1H, q, 3JHF 6.7, He). 19F NMR (376 MHz, Chloroform-d) δ -
78.4 (d, 3JFH 6.7, CF3). 13C NMR (101 MHz, Chloroform-d) δ 149.8 (s, Ar-C4), 148.4 (s, Ar-
C1), 136.1 (s, Ar-C2), 131.5 (s, Ar-C3), 124.4 (q, 1JCF 283, C7), 124.0 (s, Ar-C5), 70.5 (q, 2JCF 
32, C6). GC-MS: 3.46 mins, m/z = 177.1 (77 %, [M]+ ), 108.2 (100, [M-CF3]+), 80.1 (22, 
[C5H5N+H); as compared to literature data.57 
 
 
1-(6-bromo-3-pyridinyl)-2,2,2-trifluoroethanol (2j). 6-Bromonicotinaldehyde, 1j, (5.57 
g, 30.1 mmol) and TMSCF3 (5.1 g, 36 mmol) gave 1-(6-bromo-3-pyridinyl)-2,2,2-
trifluoroethanol, 2j, (2.40 g, 31 %) as a very dark orange, translucent liquid. 1H NMR (400 
MHz, Chloroform-d) δ 8.39 (1H, d, 4JHH 2.5, Hc), 7.76 (1H, dd, 3JHH 8.4, 4JHH 2.5, Hb), 7.52 
(1H, dd, 3JHH 8.4, 5JHH 0.7, Ha), 5.97 (1H, s, OH), 5.10 (1H, q, 3JHF 6.2, Hd). 19F NMR (376 
MHz, Chloroform-d) δ -78.4 (d, 3JFH 6.2, CF3). 13C NMR (101 MHz, Chloroform-d) δ 149.1 
(s, Ar-C4), 142.6 (s, Ar-C1), 138.3 (s, Ar-C2), 130.5 (s, Ar-C5), 128.4 (s, Ar-C5), 123.9 (q, 
1JCF 282.4, C7), 69.7 (q, 2JCF 33, C6). GC-MS: 3.84 mins, m/z = 255.0 (41 %, [M]+ ), 186.0 
(100, [M-CF3]+), 77.1 (97, [C5H5N]+). HRMS (ASAP, ES+) m/z calculated for C7H6NOF3Br 




 1-(2-Methoxyphenyl)-2,2,2-trifluoroethanol (2l). 2-Methoxybenzaldehyde, 1l, (4.23 g) 
and TMSCF3 (5.1 g, 36 mmol) gave 1-(2-methoxyphenyl)-2,2,2-trifluoroethanol, 2l, (3.80 
g, 59 %) as a clear, orange liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.40 (1H, d, 3JHH 
8.1, Hb), 7.37 (1H, ddd, 3JHH 8.1, 3JHH 7.8, 4JHH 1.7, Hc),  7.02 (1H, td, 3JHH 7.8, 4JHH 1.1, Hd), 
6.96 (1H, d, 3JHH 7.8, He), 5.29 (q, 3JHF 7.1, Hf), 3.88 (3H, s, Ha), 3.78 (1H, s, OH). 19F NMR 
(376 MHz, Chloroform-d) δ -78.1 (d, 3JFH 7.1, CF3). 13C NMR (101 MHz, Chloroform-d) δ 
157.7 (s, Ar-C2), 130.7 (s, Ar-C3), 129.4 (s, Ar-C6), 124.8 (q, 1JCF 283, C9), 122.3 (s, Ar-C7), 






















m/z = 206.0 (83 %, [M]+ ), 137.3 (100, [M – CF3]+), 121.1 (28, [C6H5CHOCH3]+), 107.1 (96, 
[C6H4OMe]+, 94.1 (24, [PhOH]+), 77 (41, [Ph]+); as compared to literature data.54 
 
 
 1-(2-Napthyl)-2,2,2-trifluoroethanol (2n). 2-Napthaldehyde, 1n, (4.72 g, 30.2 mmol) 
and TMSCF3 (5.1 g, 36 mmol) reacts to give 1-(2-napthyl)-2,2,2-trifluoroethanol, 2n, 
(4.16 g, 61 %) as a pale, yellow solid. 1H NMR (400 MHz, Chloroform-d) δ 7.94 (1H, s, Ar-
H), 7.88 (2H, t, J 8.7, Ar-H), 7.87 (1H, d, J 2.9, Ar-H), 7.57 (1H, d, J 9.4, Ar-H), 7.54 (1H, t, 
J 5.9, Ar-H), 7.54 (1H, d, J 7.3, Ar-H), 5.17 (1H, q, 3JHF 6.7, Ha), 2.90 (1H, s, OH). 19F NMR 
(376 MHz, Chloroform-d) δ -78.0 (d, 3JFH 6.7, CF3). 13C NMR (101 MHz, Chloroform-d) δ 
133.9 (s, Ar-C6), 133.0 (s, Ar-C1), 131.4 (s, Ar-C10), 128.7 (s, Ar-C7), 128.4 (s, C9), 127.9 
(s, C8), 127.5 (s, C5), 127.0(s, C2), 126.7 (s, C4), 124.5 (q, 1JCF 282, C12), 124.4 (s, C3), 
73.1 (q, 2JCF 32, C11). GC-MS: 4.34 mins, m/z = 226.1 (70 %, [M]+ ), 157.1 (75, [M-H-CF3]+), 
129.2 (100, [M–CHOHCF3+2H]+), 128.1 (55, [M-CHOHCF3+H]+), 127.1 (40, [M-















3.3 Synthesis of 1-phenyl-1,2,2,2-tetrafluoroethane derivatives (3a-j, l): 
General procedure – 1-Aryl-2,2,2-trifluoroethanol 2 (10 mmol) was dissolved in DCM 
(40 mL) and stirred at 0 oC. Diethylaminosulfur trifluoride, DAST, (3.54 g, 22 mmol) 
dissolved in DCM (10 mL) was added to the reaction mixture. The reaction was allowed 
to warm to RT and stirred for 48 hours. Water (50 mL) and DCM (50 mL) were added to 
the reaction mixture, followed by neutralisation with NaHCO3. The organic layer was 
washed with water (2 x 50 mL) and the solvent evaporated to yield product 3, which did 
not require any further purification. 
 
 
1-Phenyl-1,2,2,2-tetrafluoroethane (3a). 1-Phenyl-2,2,2-trifluoroethanol, 2a, (1.76 g, 
10 mmol) and DAST (3.54 g, 22 mmol) gave 1-phenyl-1,2,2,2-tetrafluoroethane, 3a, (1.34 
g, 75 %) as a clear, orange liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.53 – 7.42 (5H, m, 
Ar-H), 5.60 (1H, dq, 2JHF 44.1, 3JHF 6.2, Ha). 19F NMR (376 MHz, Chloroform-d) δ -78.8 (3F, 
dd, 3JFF 12.9, 3JFH 6.2, CF3), -194.6 (1F, dq, 2JFH 44.1, 3JFF 12.9, CFH). 13C NMR (101 MHz, 
Chloroform-d) δ 130.6 (d, 4JCF 2, Ar-C2), 130.4 (d, 2JCF 20, Ar-C4), 128.9 (s, Ar-C1), 127.3 
(d, 3JCF 7, Ar-C3), 122.4 (qd, 1JCF 281, 2JCF 29, C6), 89.1 (dq, 1JCF 186, 2JCF 35, C5). GC-MS: 
2.01 mins m/z = 178.0 (82 %, [M]+ ), 159.1 (8, [M-F]+), 109.2 (100 %, [M-CF3]+), 83.0 (35 





trifluoroethanol, 2b, (1.77 g, 6.97 mmol) and DAST (3.54 g, 22 mmol) gave 1-(4-
bromophenyl)-1,2,2,2-tetrafluoroethane, 3b (0.88 g, 49 %) as an opaque, dark orange 
liquid. 1H NMR (700 MHz, Chloroform-d) δ 7.59 (2H, d, 3JHH 8.3, Ha), 7.33 (2H, m, 3JHH 8.3, 
Hb), 5.56 (1H, dq, 2JHF 44.2, 3JHF 5.9, Hc). 19F NMR (376 MHz, Chloroform-d) δ -78.87 (3F, 
dd, 3JFF 13.0, 3JFH 5.9, CF3), -195.12 (1F, dq, 2JFH 44.2, 3JFF 13.0, CFH). 13C NMR (176 MHz, 
Chloroform-d) δ 132.2 (s, Ar-C2), 129.4 (dq, 2JCF 21, 3JCF 1, Ar-C4), 128.9 (dq, 3JCF 7, 4JCF 1, 

























88.5 (dq, 1JCF 187, 2JCF 35, C5). GC-MS: 3.0 mins m/z = 256.0 (54 %, [M]+ ), 187.0 (100 %, 





trifluoroethanol, 2c, (1.77 g, 8.39 mmol) and DAST (3.25 g, 20.17 mmol) gave 1-(4-
chlorophenyl)-1,2,2,2-tetrafluoroethane, 3c, (0.88 g, 40 %) a translucent, orange liquid. 
1H NMR (700 MHz, Chloroform-d) δ 7.44 (2H, d, 3JHH 8.7, Ha), 7.40 (2H, d, 3JHH 8.7, Hb), 
5.58 (1H, dq, 2JHF 44.1, 3JHF 6.0, Hc). 19F NMR (376 MHz, Chloroform-d) δ -78.9 (3F, dd, 
3JFF 13.0, 3JFH 6.0, CF3), -194.8 (1F, dq, 2JFH 44.1, 3JFF 13.0, CFH). 13C NMR (176 MHz, 
Chloroform-d) δ 136.8 (s, Ar-C1(35Cl)), 129.2 (s, Ar-C2), 128.8 (d, 2JCF 20, Ar-C4), 128.65 
(d, 3JCF 7, Ar-C3), 122.1 (qd, 1JCF 282, 2JCF 29, C6), 88.5 (dq, 1JCF 187, 2JCF 35, C5). GC-MS: 
2.7 mins m/z = 211.95 (70 %, M+ ), 143.2 (100 %, [M-CF3]+), 107.1 (58 %, [M-CF3-HCl]+/ 





trifluoroethanol, 2d, (1.68 g, 7.6 mmol) and DAST (3.54 g, 22 mmol) gave 1-(4-
nitrophenyl)-1,2,2,2-tetrafluoroethane, 3d, (1.81 g, 94 %) as an opaque, dark brown 
liquid. 1H NMR (400 MHz, Chloroform-d) δ 8.32 (1H, d, 3JHH 8.5, Ha), 7.67 (1H, d, 3JHH 8.5, 
Hb), 5.75 (1H, dq, 2JHF 44.0, 3JHF 5.8, Hc). 19F NMR (376 MHz, Chloroform-d) δ -78.5 (3F, 
dd, 3JFF 12.7, 3JFH 5.9, CF3), -197.4 (1F, dq, 2JFH 44.0, 3JFF 12.7, CFH). 13C NMR (101 MHz, 
Chloroform-d) δ 149.3 (s, Ar-C1), 136.8 (d, 2JCF 20, Ar-C4), 128.2 (d, 3JCF 7, Ar-C3), 124.0 
(s, Ar-C2), 121.8 (qd, 1JCF 282, 2JCF 28, C6), 88.0 (dq, 1JCF 189, 2JCF 35, C5). GC-MS: 3.93 
mins m/z = 223.0 (61 %, M+ ), 177.0 (24, [M-H-NO2]+), 154.1 (50, [M-CF3]+), 127.1 (100, 
[CHFPhOH+2H]+), 107.1 (CHPhOH]+). HRMS (LC-MS, ES-) m/z calculated for C8H4F4NO2 





























trifluoroethanol, 2e, (2.11 g, 10.14 mmol) and DAST (3.54 g, 22 mmol) gave 1-(4-
methoxyphenyl)-1,2,2,2-tetrafluoroethane, 3e, (1.09 g, 52 %) as a clear, pale orange 
liquid. 1H NMR (700 MHz, Chloroform-d) δ 7.39 (2H, d, 3JHH 8.5, Ar-Hb), 6.96 (2H, d, 3JHH 
8.5, Ar-Hc), 5.52 (1H, dq, 2JHF 43.9, 3JHF 6.2, Hd), 3.84 (3H, s, Ha). 19F NMR (376 MHz, 
Chloroform-d) δ -78.9 (3F, dd, 3JFF 13.5, 3JFH 6.2, CF3), -190.8 (1F, dq, 2JFH 43.9, 3JFF 13.5, 
CFH). 13C NMR (176 MHz, Chloroform-d) δ 161.4 (d, J 2, Ar-C2), 129.0 (d, 3JCF 6, Ar-C4), 
122.5 (qd, 1JCF 281, 2JCF 30, C7), 122.4 (d, 2JCF 21, Ar-C5), 114.3 (s, C3), 88.9 (dq, 1JCF 185, 
2JCF 35, C6), 55.50 (s, C1). GC-MS: 3.0 mins m/z = 208.1 (74 %, M+ ), 139.3 (100 %, [M-





trifluoroethanol, 2f, (1.79 g, 9.2 mmol) and DAST (3.54 g, 22 mmol) gave 1-(4-
fluorophenyl)-1,2,2,2-tetrafluoroethane, 3f, (2.28 g, 81 %) as a translucent, light orange 
liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.46 (2H, dd, 3JHH 8.1, 3JHF 5.2, Hb), 7.14 (2H, 
dd, 3JHF 8.5, 3JHH 8.1, Ha), 5.58 (1H, dq, 2JHF 44.0, 3JHF 6.0, Hc). 19F NMR (376 MHz, 
Chloroform-d) δ -79.0 (3F, dd, 3JFF 13.0, 3JFH 6.0, CF3), -110.1 (1F, tt, 3JFH 8.5, 4JFH 5.2, Ar-
F), -193.1 (1F, dq, 2JFH 44.0, 3JFF 13.0, CFH). 13C NMR (101 MHz, Chloroform-d) δ 164.1 (d, 
1JCF 250, Ar-C1), 129.4 (dd, 3JCF 9, 3JCF 7, Ar-C3), 126.3 (d, 2JCF 21, Ar-C4), 122.2 (qd, 1JCF 
282, 2JCF 29, C6), 116.1 (d, 2JCF 22, Ar-C2), 88.5 (dq, 1JCF 187, 2JCF 35, C5). GC-MS: 2.04 
mins m/z = 196.0 (91 %, M+ ), 128.1 (82, [M-CF3+H]+), 127.2 (100, [M-CF3]+), 101.0 (24, 








































phenyl)-2,2,2-trifluoroethanol, 2g, (2.49 g, 10.1 mmol) and DAST (3.30 g, 20.5 mmol) 
gave 1-(4-trifluoromethylphenyl)-1,2,2,2-tetrafluoroethane, 3g, (0.32 g, 12 %) as a 
translucent, dark orange liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.73 (2H, dq, 3JHH 
8.2, 4JHF 0.9, Ha), 7.60 (2H, dq, 3JHH 8.2, 5JHF 0.7, Hb), 5.67 (1H, dq, 2JHF 44.4, 3JHF 6.0, Hc). 
19F NMR (376 MHz, Chloroform-d) δ -63.0 (3F, s, Ar-CF3), -78.7 (3F, dd, 3JFF 12.8, 3JFH 6.0, 
CF3), -196.9 (1F, dq, 2JFH 44.4, 3JFF 12.8, CFH). 13C NMR (101 MHz, Chloroform-d) δ 134.1 
(q, 2JCF 20, Ar-C2), 132.8 (qd, J 33, 2, Ar-C5), 127.6 (dq, 3JCF 7, 4JCF 1, Ar-C4), 125.9 (q, 3JCF 
4, Ar-C3), 123.8 (q, 1JCF  273, C1), 122.0 (qd, 1JCF 282, 2JCF 28, C7), 88.3 (dq, 1JCF 188, 2JCF 
35, C6). GC-MS: 2.1 mins m/z = 246.0 (41 %, M+ ), 227 (18 %, [M-F]+), 177.0 (100 %, [M-




trifluoroethanol, 2h, (1.74 g, 9.2 mmol) and DAST (3.54 g, 22 mmol) gave 1-(4-
methylphenyl)-1,2,2,2-tetrafluoroethane, 3h, (0.36 g, 21 %) as a viscous, translucent, 
dark orange liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.35 (2H, d, 3JHH 7.9, Hb), 7.25 
(2H, dd, 3JHH 7.9, Hc), 5.55 (1H, dq, 2JHF 44.1, 3JHF 6.1, Hd), 2.39 (3H, s, Ha). 19F NMR (376 
MHz, Chloroform-d) δ -78.8 (3F, dd, 3JFF 13.1, 3JFH 6.1, CF3), -193.3 (1F, dq, 2JFH 44.1, 3JFF 
13.1, CFH). 13C NMR (101 MHz, Chloroform-d) δ 140.8 (d, 2JCF 2, Ar-C2), 129.5 (s, Ar-C3), 
127.5 (d, 2JCF 19, Ar-C5), 127.3 (d, 3JCF 6, Ar-C4), 122.4 (qd, 1JCF 281, 2JCF 30, C6), 89.1 (dq, 
1JCF 186, 2JCF 35, C7), 21.5 (s, C1). GC-MS: 2.44 mins m/z = 192.1 (58 %, M+ ), 173.1 (6, 
[M-F]+), 123.2 (100, [M-CF3]+), 103.1 (20, [M-CF3-HF/ C8H7]+), 77.0 (18, [Ph]+); as 
































3-(1,2,2,2-Tetrafluoro-ethyl)-pyridine (3i). 1-(3-Pyridyl)-2,2,2-trifluoroethanol, 2i, (1.77 
g, 10.0 mmol) and DAST (3.54 g, 22 mmol) gave 3-(1,2,2,2-tetrafluoro-ethyl)-pyridine, 
3i, (1.04 g, 58 %) as a translucent, dark orange liquid. 1H NMR (400 MHz, Chloroform-d) 
δ 8.73 (1H, dd, 3JHH 4.7, 4JHH 1.4, Ar-Ha), 8.69 (1H, s, Ar-Hd), 7.83 (1H, dd, 3JHH 8.0, 4JHH 1.4, 
Ar-Hc), 7.39 (1H, dd, 3JHH 8.0, 3JHH 4.7, Ar-Hb), 5.66 (1H, dq, 2JHF 44.1, 3JHF 6.0, Ar-He). 19F 
NMR (376 MHz, Chloroform-d) δ -78.82 (3F, dd, 3JFF 13.1, 3JFH 6.0, CF3), -197.37 (1F, dq, 
2JFH 44.1, 3JFF 13.1, CFH). 13C NMR (101 MHz, Chloroform-d) δ 151.8 (d, 4JCF 2, Ar-C2), 
148.5 (d, 3JCF 7, Ar-C3), 134.9 (d, 4JCF 6, Ar-C4), 126.4 (d, 2JCF 20, Ar-C5), 123.7 (s, Ar-C1), 
122.0 (qd, 1JCF 282, 2JCF 29, C7), 87.2 (dq, 1JCF 188, 2JCF 36, C6). GC-MS: 2.24 mins m/z = 
179.1 (100 %, M+ ), 160.1 (13, [M-F]+), 110.1 (100, [M-CF3]+), 83.1 (53, [CF3CH2]+). HRMS 




trifluoroethanol, 2j, (1.95 g, 7.6 mmol) and DAST (3.54 g, 22 mmol) gave 2-bromo-5-
(1,2,2,2-tetrafluoro-ethyl)-pyridine, 3j, (1.21 g, 62 %) as a translucent, dark brown liquid. 
1H NMR (400 MHz, Chloroform-d) δ 8.41 (1H, s, Hc), 7.65 (1H, dd, 3JHH 8.3, 4JHH 2.7, Hb), 
7.57 (d, 3JHH 8.3, Ha), 5.64 (1H, dq, 2JHF 43.7, 3JHF 5.9, Hd). 19F NMR (376 MHz, Chloroform-
d) δ -79.0 (3F, dd, 3JFF 13.2, 3JFH 5.9, CF3), -198.0 (1F, dq, 2JFH 43.7, 3JFF 13.2, CFH). 13C NMR 
(101 MHz, Chloroform-d) δ 148.9 (d, 3JCF 7, Ar-C4), 144.7 (s, Ar-C1), 137.0 (d, 3JCF 6, Ar-
C3), 128.5 (s, Ar-C2), 125.7 (d, 2JCF 22, Ar-C5), 121.7 (qd, 1JCF 282, 2JCF 29, C7), 86.7 (dq, 
1JCF 188, 2JCF 36, C6). GC-MS: 3.16 mins m/z = 257.0 (100 %, M+ ), 188.0 (97, [M-CF3]+), 
178.1 (59, [M-Br]+), 109.1 (54, [M-Br-CF3]+). HRMS (ASAP, ES+) m/z calculated for 






























trifluoroethanol, 2l, (2.07 g, 10.05 mmol) and DAST (3.66 g, 22.7 mmol) gave 1-(2-
methoxyphenyl)-1,2,2,2-tetrafluoroethane, 3l, (0.89 g, 43 %) as a translucent, dark 
orange liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.52 (1H, dd, 3JHH 7.6, 4JHH 1.9, Hb), 
7.42 (1H, dddd, 3JHH 8.4, 3JHH 7.6, 4JHH 1.9, 5JHF 1.0, Hd), 7.05 (1H, td, 3JHH 7.6, 4JHH 1.2, Hc), 
6.94 (1H, dt, 3JHH 8.4, 4JHH 1.2, 4JHF 1.2, He), 6.18 (1H, dq, 2JHF 43.8, 3JHF 6.1, Hf), 3.85 (3H, 
s, Ha). 19F NMR (376 MHz, Chloroform-d) δ -78.8 (3F, dd, 3JFF 13.0, 3JFH 6.1, CF3), -198.1 
(1F, dq, 2JFH 43.8, 3JFF 13.0, CFH). 13C NMR (101 MHz, Chloroform-d) δ 157.3 (d, 3JCF 5, Ar-
C2), 131.7 (d, 4JCF 2.1, Ar-C3), 128.1 (d, 3JCF 7, Ar-C6), 122.74 (qd, 1JCF 282, 2JCF 30, C9), 
120.9 (s, Ar-C4), 119.0 (d, 2JCF 21, Ar-C7), 110.9 (s, Ar-C5), 83.2 (dq, 1JCF 182, 2JCF 36, C8), 
55.8 (s, C1). GC-MS: 2.84 mins m/z = 208.1 (91 %, M+ ), 189.1 (1, [M-F]+), 139.1 (93, [M-
CF3]+), 109.1 (43, [PhO(H)Me]+ ), 91.2 (100, [M-CFHCF3-Me-2H]+), 83.1 (15, [CHCF3]+). 
HRMS (ESI, ES+) m/z calculated for C9H8F4O [M-F]+ 189.0527, found 189.0539. 
 
 
1-(2-napthyl)-1,2,2,2-tetrafluoroethane (3n). 1-(2-napthyl)-2,2,2-trifluoroethanol, 2n, 
(2.29 g, 10.1 mmol) and DAST (3.54 g, 22 mmol) gave 1-(2-napthyl-1,2,2,2-
tetrafluoroethane, 3n, (1.70 g, 74 %) as an orange solid. 1H NMR (400 MHz, Chloroform-
d) δ 7.96 (1H, s, Ar-H), 7.93 (1H, d, 3JHF 8.8, Ar-H), 7.93 – 7.86 (1H, m, Ar-H), 7.81 (1H, dd, 
J 9.3, J 3.2, Ar-H), 7.60 – 7.52 (2H, m, Ar-H), 7.48 (1H, ddd, J 10.9, J 7.2, J 2.4, Ar-H), 5.77 
(1H, dq, 2JHF 44.2, 3JHF 6.1, Ha). 19F NMR (376 MHz, Chloroform-d) δ -78.4 (3F, dd, 3JFF 
13.1, 3JFH 6.1, CF3), -193.8 (1F, dq, 2JFH 44.2, 3JFF 13.1, CFH). 13C NMR (101 MHz, 
Chloroform-d) δ 134.2 (d, 5JCF 1.4, Ar-C1), 132.8 (s, Ar-C6), 128.9 (s, Ar-C3), 128.5 (s, Ar-
C4), 128.0 (s, Ar-C2), 127.7 (d, 2JCF 20, Ar-C10), 127.5 (s, Ar-C5), 127.0 (s, Ar-C8), 126.7 
(d, 3JCF 8, Ar-C9), 123.6 (d, 2JCF 8 Ar-C7), 122.49 (qd, 1JCF 282, 2JCF 29, C11), 89.31 (dq, 1JCF 































[M-C4H3]+), 159.2 (100 %, [M-CF3]+), 79.6 (21 %, [PhH+H]+); as compared to literature 
data.34 
3.4 Reaction of fluorinated aromatics with nitronium tetrafluoroborate: 
General procedure – Nitration (5a, n-o). Nitronium tetrafluoroborate, NO2BF4, 
(0.28 g, 2.1 mmol) was dissolved in nitromethane (10 mL) while being stirred at 0 oC 
under argon. 1-Phenyl-1,2,2,2-tetrafluoroethane (2 mmol) in nitromethane (10 mL) and 
then was added to the reaction mixture. The reaction was allowed to warm to RT and 
stirred for 4 d. The reaction was quenched by the addition of water (20 mL) and washed 
by 5 % NaHCO3 solution (3x 25 mL) before the product was extracted in DCM (3x 25 mL). 
The organic layer was dried (MgSO4) and concentrated to yield the product mixture. 
 
 
1-(3-nitrophenyl)-1,2,2,2-tetrafluoroethane (5a). 1-Phenyl-1,2,2,2-tetrafluoroethane, 
3a, (0.36 g, 2.1 mmol) and nitronium tetrafluoroborate (0.29 g, 2.2 mmol) gave 1-(3-
nitrophenyl)-1,2,2,2-tetrafluoroethane, 5a, (0.25 g, 55 %) as a clear, pale orange liquid. 
1H NMR (400 MHz, Chloroform-d) δ 8.36 (1H, dd, 3JHH 3.5, 4JHH 1.4, Ar-Ha), 8.33 (1H, d, 
4JHF 8.1, Ar-Hd), 7.82 (1H, dd, 3JHH 7.7, 3JHH 3.5, Ar-Hb), 7.69 (1H, ddd, 4JHF 8.8, 3JHH 7.7, 4JHH 
1.4, Ar-Hc), 5.74 (1H, dq, 2JHF 44.1, 3JHF 5.9, He). 19F NMR (376 MHz, chloroform-d) δ -78.7 
(3F, dd, 3JFF 12.8, 3JFH 5.9, CF3), -196.5 (1F, dq, 2JFH 44.1, 3JFF 12.8, CFH). 13C NMR (101 
MHz, chloroform-d) δ 132.9 (d, 3JCF 7, Ar-C1), 130.2 (s, Ar-C3), 128.2 (d, 3JCF 7, Ar-C5), 
125.4 (d, 4JCF 1, Ar-C2), 124.0 (s, Ar-C4), 122.3 (d, 2JCF 8, Ar-C6), 121.8 (qd, 1JCF 282, 2JCF 
28, C8), 87.9 (dq, 1JCF 189, 2JCF 36, C7). GC-MS: 3.27 mins, m/z = 223.1 (54 %, M+ ), 204.0 
(7, [M-F]+), 127.1 (100, [FC6H4NHOH]+), 177.1 (25, [M-NO2]+), 154.1 (65, [M-CF3]+), 108.1 




















3-Nitro-α,α,α-trifluorotoluene (5o). α,α,α-Trifluorotoluene 3o (0.72 g, 4.92 mmol) and 
nitronium tetrafluoroborate (0.7 g, 5.3 mmol) gave 3-nitro-α,α,α-trifluorotoluene, 5o, 
(0.67 g, 71 %) as a clear, light orange liquid. 1H NMR (400 MHz, Chloroform-d) δ 8.51 
(1H, s, Ar-Hd), 8.44 (1H, dd, 3JHH 8.1, 4JHH 2.0, Ar-Hc), 7.98 (1H, dd, 3JHH 8.1, 4JHH 2.0, Ar-
Ha), 7.74 (1H, t, 3JHH 8.1, Ar-Hb). 19F NMR (376 MHz, chloroform-d) δ -63.0 (s, CF3). 13C 
NMR (101 MHz, chloroform-d) δ 148.4 (s, Ar-C2), 132.5 (q, 2JCF 34, Ar-C6), 131.3 (q, 3JCF 
4, Ar-C1), 130.5 (s, Ar-C3), 126.8 (s, Ar-C4), 123.0 (q, 1JCF 273, C7), 121.0 (q, 3JCF 4, Ar-C5). 
GC-MS: 2.96 mins, m/z = 191.0 (82 %, M+ ), 145.2 (100, [M-NO2]+), 125.1 (30, [M-




1-Nitro-3-(trifluoromethoxy) benzene (5p). (Trifluoromethoxy) benzene, 3p, (0.80 g, 
4.92 mmol) and nitronium tetrafluoroborate (0.7 g, 5.3 mmol) gave 1-nitro-3-
(trifluoromethoxy) benzene, 5o, (0.70 g, 69 %) as a clear, dark yellow liquid. 1H NMR 
(400 MHz, Chloroform-d) δ 8.31 (1H, t, 3JHH 9.3, Ar-Hb), 8.31 (1H, q, 5JHF 5.5, Ar-Hd), 7.37 
(2H, dd, 3JHH 9.3, 4JHH 1.1, Ar-Ha), 7.37 (2H, dd, 3JHH 9.3, 4JHH 1.1, Ar-Hc). 19F NMR (376 
MHz, chloroform-d) δ -57.8 (s, CF3). 13C NMR (101 MHz, chloroform-d) δ 153.7 (q, 4JCF 2, 
Ar-C1), 146.0 (s, Ar-C2), 134.4 (s, Ar-C3), 126.9 (q, 3JCF 167.0, Ar-C6), 125.9 (s, Ar-C4), 
121.0 (q, 4JCF 2, Ar-C5), 120.3 (q, 1JCF 260, C7). GC-MS: 2.99 mins, m/z = 207.0 (95 %, M+  
), 191.0 (4, [M-O]+), 177.0 (34, [M-HF]+), 161.1 (15, [M-NO2]+), 122.1 (14, [M-OCF3), 95.1 























3.5 Synthesis of 2,2,3,3,3-pentafluoroaryl derivatives: 
General Procedure – Pentafluoroethylation reactions (2k&m). Aldehyde (30 
mmol) and CF3CF2SiMe3 (6.9 g, 6.3 mL, 36 mmol) were dissolved in THF (30 mL) at 0oC 
under an atmosphere of argon. TBAF (0.1 g) was added and the reaction was allowed to 
warm to RT and stirred for 3 h. 6 M HCl (6 mL) solution was added and the reaction 
stirred for 48 h. The mixture was extracted with ether (3 x 30 mL), washed with water (2 
x 50 mL) and brine (50 mL). The organic layer was dried (MgSO4) and solvent evaporated 
to give the pentafluoro- alcohol product. 
 
 
1-Phenyl-2,2,3,3,3-pentafluoropropan-1-ol (2k). Benzaldehyde, 1k, (3.22 g, 30.4 mmol) 
and TMSCF2CF3 (6.9 g, 36 mmol) gave 1-phenyl-2,2,3,3,3-pentafluoropropan-1-ol, 2k, 
(4.12 g, 60 %) as a clear, pale yellow liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.47 (2H, 
dd, 3JHH 6.8, 3JHH 3.2, Ar-Hb), 7.45 -7.38 (3H, m, Ar-Ha), 5.12 (1H, dd, 3JHF 16.7, 3JHF 7.3, 
Hc), 2.61 (1H, s, OH). 19F NMR (376 MHz, Chloroform-d) δ -81.3 (3F, s, CF3), -121.9 (1F, 
dd, 2JFF 275.8, 3JFH 7.3, F2), -129.4 (1F, dd, 2JFF 275.8, 3JFH 16.7, F1). 13C NMR (101 MHz, 
Chloroform-d) δ 134.2 (s, Ar-C4), 129.7 (s, Ar-C1), 128.7 (s, Ar-C2), 128.0 (s, Ar-C3), 119.3 
(qt, 1JCF 287, 2JCF 36, C7), 113.2 (ddq, 1JCF 261, 1JCF 255, 2JCF 36, C6), 72.1 (dd, 2JCF 28, 2JCF 
22, C5). GC-MS: 2.91 mins, m/z = 226.1 (12 %, M+ ), 159.1 (4, [M-CF3]+), 107.1 (100, [M–
CF2CF3]+), 79.1 (85, [Ph+2H]+), 77.1 (55, [Ph]+); as compared to literature data.68 
 
 
1-(3-pyridyl)-2,2,3,3,3-pentafluoropropan-1-ol (2m). 3-pyridinecarboxaldehyde, 1m, 
(3.20 g, 29.9 mmol) and TMSCF2CF3 (11.6 g, 60.52 mmol) gave 1-(3-pyridyl)-2,2,3,3,3-
pentafluoropropan-1-ol, 2m, (3.74 g, 46 %) as pale white solid. 1H NMR (400 MHz, 
Chloroform-d) 8.45 (1H, s, Hd), δ 8.38 (1H, dd, 3JHH 5.0, 4JHH 1.9, Ha), 7.90 (1H, dd, 3JHH 8.0, 
4JHH 1.9, Hc), 7.33 (1H, dd, 3JHH 8.0, 3JHH 5.0, Hb), 7.00 (1H, s, OH), 5.14 (1H, dd, 3JHF 17.4, 
3JHF 6.7, He). 19F NMR (376 MHz, Chloroform-d) δ -81.1 (3F, s, CF3), -120.4 (1F, dd, 2JFF 
276.4, 3JFH 6.7, F1), -129.4 (1F, dd, 2JFF 276.4, 3JHH 17.4, F2). 13C NMR (101 MHz, 




















2m, 23 % 
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119.2 (qt, 1JCF 287, 2JCF 36, C8), 113.3 (ddq, 1JCF 262, 1JCF 255, 2JCF 36, C7), 69.4 (dd, 2JCF 
28, 2JCF 23, C6). GC-MS: 3.40 mins, m/z = 227.0 (31 %, M+ ), 160.1 (3, [M-CF3+2H]+), 108.2 
(100, [M–CF2CF3]+), 80.1 (61, [M-CHOHCF2CF3]+). HRMS (ASAP, ES+) m/z calculated for 
C7H6NOF3Br [M+H]+, 228.0448, found 228.0456. 
3.6 Synthesis of 1-aryl-1,2,2,3,3,3-hexafluoropropane derivates (3k&m): 
General procedure – 1-Aryl-2,2,3,3,3-pentafluoropropan-1-ol 2 (10 mmol) was 
dissolved in DCM (40 mL) and stirred at 0 oC. Diethylaminosulfur trifluoride, DAST, (3.54 
g, 22 mmol) dissolved in DCM (10 mL) was added to the reaction mixture. The reaction 
was allowed to warm to RT and stirred for 48 h. Water (50 mL) and DCM (50 mL) were 
added to the reaction mixture, followed by a neutralisation with NaHCO3. The organic 




ol, 2k, (2.28 g, 10.1 mmol) and DAST (3.54 g, 22 mmol) gave 1-phenyl-1,2,2,3,3,3-
hexafluoropropane, 3k, (2.33 g, 99 %) as a translucent, dark orange liquid. 1H NMR (400 
MHz, Chloroform-d) δ 7.57 – 7.39 (5H, m, Ar-H), 5.73 (1H, ddd, 2JHF 43.8, 3JHF 17.5, 3JHF 
4.3, Ha). 19F NMR (376 MHz, Chloroform-d) δ -82.2 (3F, dd, 4JFF 11.1, 4JFH 2.2, CF3), -122.9 
(1F, ddd, 2JFF 283.9, 3JFF 11.1, 3JFH 4.3, F3), -131.6 (1F, ddd, 2JFF 283.9, 3JFH 17.5, 3JFF 15.1, 
F2), -195.7 (1F, ddp, 2JFH 43.8, 3JFF 15.1, 3/4JFF 11.1, F1). 13C NMR (101 MHz, Chloroform-d) 
δ 130.7 (d, 4JCF 2, Ar-C2), 129.8 (d, 2JCF 20, Ar-C4), 128.8 (s, Ar-C1), 127.7 (d, 3JCF 7, Ar-C3), 
119.2 (qtd, 1JCF 288, 2JCF 36, 3JCF 2, C7), 115.9 (dddq, 1JCF 263, 1JCF 254, 2JCF 37, 3JCF 29, C6), 
88.3 (ddd, 1JCF 186, 2JCF 32, 2JCF 24, C5). GC-MS: 2.15 mins m/z = 228.0 (88 %, M+ ), 189.0 
(9, [M-HF-F]+), 159.1 (4, [M-CF3]+), 109.2 (100, [M-CF2CF3]+ ), 83.1 (40, [CF3CH2]+); as 



























fluoropropan-1-ol, 2m, (2.17 g, 12.3 mmol) and DAST (3.54 g, 22 mmol) gave 1-(3-
pyridyl)-1,2,23,3,3-hexafluoropropane, 3m, (4.69 g, 70 %) as a dark orange, viscous 
liquid. 1H NMR (400 MHz, Chloroform-d) δ 8.57 (1H, dd, 3JHH 4.9, 4JHH 0.9, Ha), 8.54 (1H, 
s, Hd), 7.71 (1H, dd, 3JHH 8.0, 4JHH 0.9, Hc), 7.30 (1H, dd, 3JHH 8.0, 3JHH 4.9, Hb), 5.78 (1H, 
ddd, 2JHF 43.7, 3JHF 17.9, 3JHF 3.9, He). 19F NMR (376 MHz, Chloroform-d) δ -82.06 (3F, dd, 
4JFF 11.0, 4JFH 1.1, CF3), -122.72 (1F, ddd, 2JFF 285.5, 3JFF 11.0, 3JFH 3.9, F2), -131.52 (1F, ddd, 
2JFF 285.5, 3JFH 17.9, 3JFF 15.0, F3), -198.58 (1F, ddp, 2JFH 43.7, 3JFF 15.0, 3/4JFF 11.0, F1). 13C 
NMR (101 MHz, Chloroform-d) δ 151.6 (d, 4JCF 2, Ar-C2), 148.5 (d, 3JCF 7, Ar-C3), 135.2 (d, 
3JCF 7, Ar-C4), 125.7 (d, 2JCF 21, Ar-C5), 123.5 (s, Ar-C1), 120.4 – 116.3 (qtd, 1JCF 290, 37, 
2, C8), 115.0 – 107.0 (m (qtd), C7), 86.4 (ddd, 1JCF 186, 2JCF 33, 2JCF 24, C6). GC-MS: 2.34 
mins m/z = 229.0 (94 %, M+ ), 190.0 (9, [M-HF-F]+), 159.1 (4, [M-CF3]+), 110.25 (100, [M-
CF2CF3]+), 83.1 (40, [CF3CH2]+). HRMS (ASAP, ES+) m/z calculated for C8H6F6N [M+H]+ 
230.0404, found 230.0410. 
3.7 Dehydrofluorination reactions (4k&m): 
General procedure – (4k&m). 1,2,2,3,3,3-Hexafluoropropane aryl derivatives (5.2 
mmol) was dissolved in dry THF (30 mL) and stirred at 0 oC under argon. KOtBu (1.12 g, 
10 mmol) was added to the reaction mixture, which was allowed to warm to RT and 
stirred overnight. The reaction was quenched by the addition of water (50 mL), followed 
by a neutralisation with NaHCO3 and extracted with ether (3x 30 mL). The organic layer 
was washed with water (2 x 50 mL) and brine (50 mL), dried (MgSO4) and concentrated 




hexafluoropropane, 3k, (1.18 g, 5.17 mmol) and KOtBu (1.11 g, 9.91 mmol) gave 1-


































1H NMR (400 MHz, Chloroform-d) δ 7.69 – 7.66 (3H, m, Ar-Ha), 7.48 – 7.44 (2H, m, Ar-
Hb). 19F NMR (376 MHz, Chloroform-d) δ -67.0 (3F, dd, 3JFF 22.0, 4JFF 10.6, CF3), -146.3 
(1F, dq, 3JFF 131.7, 4JFF 22.0, F2), -169.5 (1F, dq, 3JFF 131.7, 4JFF 10.6, F1). 13C NMR (101 
MHz, Chloroform-d) δ 151.4 (ddq, 1JCF 250, 2JCF 36, 3JCF 3, Ar-C5), 138.4 (ddq, 1JCF 249, 2JCF 
51, 2JCF 40, Ar-C6), 131.3 (d, J 2, Ar-C1), 128.9 (d, 4JCF 2, Ar-C2), 127.2 (dd, 2JCF 24, 3JCF 6, 
Ar-C4), 126.6 (d, 3JCF 8, Ar-C3), 119.5 (qdd, 1JCF 272, 2JCF 36, 3JCF 4, C7). GC-MS: 2.34 mins 
m/z = 208.0 (100 %, M+ ), 189.0 (17, [M-F]+), 169.1 (17, [M-F-F-H]+), 158.1 (100, [M-





hexafluoropropane, 3m, (0.94 g, 4.10 mmol) and KOtBu (0.9 g, 8.04 mmol) gave 1-(3-
pyridiyl)-1,2,3,3,3-pentafluoroprop-1-ene, 4m, (7.20 g, 89 %) as a dark red solid. 1H NMR 
(400 MHz, Chloroform-d) δ 8.95 (1H, d, 4JHF 2.3, Ar-Hd), 8.72 (1H, dd, 3JHH 4.9, 4JHH 1.9, 
Ar-Ha), 7.99 (1H, dt, 3JHH 8.2, 4JHF 2.0, 4JHH 1.9, Ar-Hc), 7.44 (1H, dd, 3JHH 8.2, 3JHH 4.9, Ar-
Hb). 19F NMR (376 MHz, Chloroform-d) δ -67.2 (3F, dd, 3JFF 21.8, 4JFF 10.4, CF3), -149.1 
(1F, dq, 3JFF 131.9, 3JFF 21.8, F2), -167.3 (1F, dq, 3JFF 131.9, 4JFF 10.4, F1). GC-MS: 2.46 mins 
m/z = 208.0 (100 %, M+ ), 190.0 (19, [M-F]+), 170.0 (9, [M-F-F-H]+), 159.1 (36, [M-CF3+F]+), 
140.1 (16, [M-CF3]+), 112.1 (4, [M-CFCF3+H]+), 106.0 (19, [M-CF3-F-F+4H]+). HRMS (ASAP, 



























Chapters 4: Appendices 
Appendix 1- Crystallographic data for compound 2d 
Table 1 Crystal data and structure refinement for 18srv145.  
Identification code  18srv145 
Empirical formula  C8H6F3NO3 
Formula weight  221.14 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/c 
a/Å  9.2387(3) 
b/Å  9.6082(3) 
c/Å  10.3503(4) 
α/°  90 
β/°  109.1384(14) 
γ/°  90 
Volume/Å3  867.99(5) 
Z  4 
ρcalcg/cm3  1.692 
μ/mm-1  0.169 
F(000)  448.0 
Crystal size/mm3  0.21 × 0.2 × 0.19 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.666 to 59.996 
Index ranges  -12 ≤ h ≤ 12, -13 ≤ k ≤ 13, -14 ≤ l ≤ 14 
Reflections collected  18381 
Independent reflections  2516 [Rint = 0.0282, Rsigma = 0.0175] 
Data/restraints/parameters  2516/0/156 
Goodness-of-fit on F2  1.069 
Final R indexes [I>=2σ (I)]  R1 = 0.0331, wR2 = 0.0938 
Final R indexes [all data]  R1 = 0.0407, wR2 = 0.0978 
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Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 18srv145. Ueq is defined as 1/3 of of the trace of the 
orthogonalised UIJ tensor. 
Atom x y z U(eq) 
F1 9179.9(9) 7186.7(8) 3356.5(7) 26.34(18) 
F2 9230.7(9) 9095.1(7) 2293.5(8) 26.94(19) 
F3 10105.6(8) 7202.1(9) 1701.1(9) 30.5(2) 
O1 6298.0(9) 8028.5(8) 1583.6(9) 20.86(19) 
O2 6059.3(11) 935.2(8) 1475.1(10) 24.0(2) 
O3 7179.2(10) 864.2(8) -57.9(9) 21.86(19) 
N1 6675.5(10) 1508.4(9) 720.9(9) 14.87(19) 
C1 7155.0(11) 5861.2(10) 962(1) 12.44(19) 
C2 6434.5(12) 5175.5(10) 1769.0(11) 14.1(2) 
C3 6253.7(12) 3739.0(11) 1682.6(11) 14.1(2) 
C4 6815.6(11) 3025.5(10) 786.3(10) 12.47(19) 
C5 7516.7(12) 3677.8(11) -44.4(11) 14.6(2) 
C6 7679.9(12) 5113.6(11) 50.5(11) 15.1(2) 
C7 7405.1(12) 7416(1) 1101.1(11) 14.4(2) 
C8 8991.5(12) 7723.5(11) 2122.0(12) 17.9(2) 
  
Table 3 Anisotropic Displacement Parameters (Å2×103) for 18srv145. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
F1 26.8(4) 27.0(4) 19.1(4) 0.2(3) -0.8(3) -1.5(3) 
F2 25.1(4) 16.3(3) 35.5(4) -5.5(3) 4.5(3) -7.7(3) 
F3 15.3(3) 35.7(4) 42.7(5) -13.3(3) 12.7(3) -3.2(3) 
O1 18.9(4) 10.4(4) 35.3(5) -0.7(3) 11.5(3) 1.4(3) 
O2 34.4(5) 12.4(4) 31.7(5) 1.4(3) 19.9(4) -1.5(3) 
O3 31.2(5) 14.6(4) 21.7(4) -4.1(3) 11.4(3) 3.5(3) 
N1 16.3(4) 11.2(4) 15.6(4) -0.9(3) 3.2(3) 1.1(3) 
C1 11.4(4) 10.6(4) 13.6(4) 0.3(3) 1.8(3) 0.2(3) 
C2 16.1(4) 11.7(4) 15.5(5) -1.3(3) 6.8(4) 0.9(3) 
C3 15.6(4) 13.0(4) 14.9(5) 0.6(3) 6.5(4) -0.4(3) 
C4 12.9(4) 9.4(4) 13.5(4) -0.2(3) 2.3(3) 1.1(3) 
C5 15.8(4) 14.7(5) 14.6(5) -1.9(4) 6.7(4) 1.4(4) 
C6 16.3(5) 15.0(5) 15.5(5) 0.8(4) 7.3(4) -1.3(4) 
C7 14.5(4) 11.3(4) 17.1(5) 0.2(4) 5.0(4) -0.7(3) 




Table 4 Bond Lengths for 18srv145. 
Atom Atom Length/Å   Atom Atom Length/Å 
F1 C8 1.3354(14)   C1 C6 1.3933(14) 
F2 C8 1.3384(12)   C1 C7 1.5113(14) 
F3 C8 1.3395(13)   C2 C3 1.3897(14) 
O1 C7 1.4060(13)   C3 C4 1.3842(14) 
O2 N1 1.2362(12)   C4 C5 1.3845(14) 
O3 N1 1.2229(12)   C5 C6 1.3877(14) 
N1 C4 1.4630(13)   C7 C8 1.5285(15) 
C1 C2 1.3926(14)         
  
Table 5 Bond Angles for 18srv145. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
O2 N1 C4 117.82(9)   C4 C5 C6 117.92(9) 
O3 N1 O2 122.98(9)   C5 C6 C1 120.44(9) 
O3 N1 C4 119.20(9)   O1 C7 C1 109.96(8) 
C2 C1 C6 120.21(9)   O1 C7 C8 108.53(9) 
C2 C1 C7 119.92(9)   C1 C7 C8 109.81(8) 
C6 C1 C7 119.86(9)   F1 C8 F2 106.82(9) 
C3 C2 C1 120.15(9)   F1 C8 F3 107.08(9) 
C4 C3 C2 118.13(9)   F1 C8 C7 112.42(9) 
C3 C4 N1 118.53(9)   F2 C8 F3 107.48(9) 
C3 C4 C5 123.14(9)   F2 C8 C7 111.18(9) 
C5 C4 N1 118.33(9)   F3 C8 C7 111.58(9) 
  
Table 6 Hydrogen Bonds for 18srv145. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
O1 H1 O21 0.85(2) 1.96(2) 2.8008(11) 168.0(18) 
1+X,1+Y,+Z 
  
Table 7 Selected Torsion Angles for 18srv145. 
A B C D Angle/˚   A B C D Angle/˚ 
O1 C7 C8 F1 61.54(11)   C2 C1 C7 C8 93.26(11) 
O1 C7 C8 F2 -58.16(11)   C3 C4 N1 O2 -0.06(14) 
O1 C7 C8 F3 -178.14(9)   C3 C4 N1 O3 -179.37(9) 
C1 C7 C8 F1 -58.68(12)   C5 C4 N1 O2 179.41(9) 
C1 C7 C8 F2 -178.38(8)   C5 C4 N1 O3 0.10(14) 
C1 C7 C8 F3 61.64(12)   C6 C1 C7 O1 155.47(9) 




Table 8 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 18srv145. 
Atom x y z U(eq) 
H7 7325.16 7821.84 190.54 17 
H1 6310(20) 8910(20) 1482(19) 39(5) 
H2 6072(17) 5690(16) 2404(15) 19(3) 
H3 5762(17) 3287(16) 2230(15) 20(4) 
H5 7861(18) 3195(17) -636(16) 23(4) 





Refinement model description  
Number of restraints - 0, number of constraints - unknown.  
Details: 
1. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups 













Appendix 2- Crystallographic data from compound 2m 
Table 1 Crystal data and structure refinement for 18srv350.  
Identification code  18srv350 
Empirical formula  C8H6F5NO 
Formula weight  227.14 
Temperature/K  120.0 
Crystal system  monoclinic 
Space group  P21/n 
a/Å  5.0833(2) 
b/Å  9.1799(4) 
c/Å  19.7715(7) 
α/°  90 
β/°  90.861(4) 
γ/°  90 
Volume/Å3  922.51(7) 
Z  4 
ρcalcg/cm3  1.635 
μ/mm-1  0.176 
F(000)  456.0 
Crystal size/mm3  0.39 × 0.27 × 0.25 
Radiation  MoKα (λ = 0.71073) 
2Θ range for data collection/°  4.892 to 58.996 
Index ranges  -6 ≤ h ≤ 7, -12 ≤ k ≤ 10, -27 ≤ l ≤ 27 
Reflections collected  8980 
Independent reflections  2560 [Rint = 0.0289, Rsigma = 0.0270] 
Data/restraints/parameters  2560/0/140 
Goodness-of-fit on F2  1.044 
Final R indexes [I>=2σ (I)]  R1 = 0.0404, wR2 = 0.0914 
Final R indexes [all data]  R1 = 0.0539, wR2 = 0.1002 





 Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 18srv350. Ueq is defined as 1/3 of of the trace of the 
orthogonalised UIJ tensor. 
Atom x y z U(eq) 
F1 10699.2(17) 6047.3(9) 3856.3(4) 33.7(2) 
F2 6830.7(16) 7065.0(10) 3760.5(4) 33.2(2) 
F3 7745(2) 8682.9(11) 4869.2(5) 42.4(3) 
F4 11814(2) 8040.9(14) 4904.2(5) 55.3(3) 
F5 8745(2) 6450.7(12) 5050.4(5) 53.6(3) 
O1 9340(2) 9803.8(11) 3646.5(5) 29.5(2) 
N1 11974(2) 6709.2(14) 1811.2(6) 28.6(3) 
C1 12097(3) 7109.4(15) 2462.5(7) 25.5(3) 
C2 10345(2) 8076.4(14) 2755.3(6) 22.4(3) 
C3 8383(3) 8667.6(15) 2342.9(7) 27.4(3) 
C4 8224(3) 8259.7(17) 1668.1(7) 31.1(3) 
C5 10040(3) 7275.7(16) 1423.9(7) 29.6(3) 
C6 10599(3) 8488.7(14) 3497.9(7) 23.2(3) 
C7 9379(3) 7319.4(15) 3941.3(7) 24.7(3) 
C8 9409(3) 7641.9(17) 4705.3(7) 33.8(3) 
  
Table 3 Anisotropic Displacement Parameters (Å2×103) for 18srv350. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
F1 44.4(5) 21.6(4) 35.1(5) 1.9(3) 0.9(4) 6.2(4) 
F2 28.0(4) 37.4(5) 34.3(5) 4.1(4) -1.6(3) -8.6(4) 
F3 58.0(6) 37.8(5) 31.9(5) -1.7(4) 16.6(4) 4.6(4) 
F4 49.8(6) 82.1(9) 33.5(5) -9.6(5) -13.7(4) -2.9(6) 
F5 89.0(8) 40.0(6) 32.2(5) 12.8(4) 11.1(5) 5.3(6) 
O1 35.3(5) 19.7(5) 33.8(6) -2.3(4) 9.4(4) 1.3(4) 
N1 32.1(6) 27.8(6) 25.9(6) -3.1(5) 2.4(5) 2.5(5) 
C1 25.8(6) 25.0(7) 25.6(7) -0.8(5) -0.4(5) 2.2(5) 
C2 23.5(6) 20.4(6) 23.3(6) -0.8(5) 1.0(5) -1.2(5) 
C3 27.7(7) 24.7(7) 29.7(7) 1.1(5) 1.9(5) 4.3(5) 
C4 31.3(7) 33.2(8) 28.7(7) 5.2(6) -3.8(5) 3.0(6) 
C5 34.5(7) 32.0(8) 22.3(7) 0.0(5) 0.0(5) -2.0(6) 
C6 24.8(6) 20.2(6) 24.8(6) -2.7(5) 1.7(5) -0.1(5) 
C7 25.9(6) 22.2(6) 25.8(7) -0.2(5) -1.2(5) 1.6(5) 
C8 42.8(8) 33.4(8) 25.2(7) 2.0(6) 0.2(6) 0.3(7) 
  
Table 4 Bond Lengths for 18srv350. 
Atom Atom Length/Å   Atom Atom Length/Å 
F1 C7 1.3585(15)   C1 C2 1.3898(18) 
F2 C7 1.3590(15)   C2 C3 1.3890(19) 
F3 C8 1.3198(18)   C2 C6 1.5199(18) 
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F4 C8 1.3302(19)   C3 C4 1.387(2) 
F5 C8 1.3349(18)   C4 C5 1.384(2) 
O1 C6 1.3996(16)   C6 C7 1.5236(18) 
N1 C1 1.3398(17)   C7 C8 1.539(2) 
N1 C5 1.3419(18)         
  
Table 5 Bond Angles for 18srv350. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C1 N1 C5 117.74(12)   F1 C7 C6 109.18(10) 
N1 C1 C2 123.67(12)   F1 C7 C8 106.81(11) 
C1 C2 C6 121.05(12)   F2 C7 C6 111.36(11) 
C3 C2 C1 117.64(12)   F2 C7 C8 106.64(11) 
C3 C2 C6 121.30(12)   C6 C7 C8 115.54(12) 
C4 C3 C2 119.36(13)   F3 C8 F4 108.52(13) 
C5 C4 C3 118.83(13)   F3 C8 F5 107.44(12) 
N1 C5 C4 122.74(13)   F3 C8 C7 112.55(12) 
O1 C6 C2 112.65(11)   F4 C8 F5 108.22(13) 
O1 C6 C7 107.20(10)   F4 C8 C7 109.78(12) 
C2 C6 C7 110.56(11)   F5 C8 C7 110.20(13) 
F1 C7 F2 106.88(11)           
  
Table 6 Hydrogen Bonds for 18srv350. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 







Table 7 Selected Torsion Angles for 18srv350. 
A B C D Angle/˚   A B C D Angle/˚ 
F1 C7 C8 F3 -167.00(11)   C2 C6 C7 F1 62.09(14) 
F1 C7 C8 F4 72.02(15)   C2 C6 C7 F2 -55.69(14) 
F1 C7 C8 F5 -47.09(16)   C2 C6 C7 C8 -177.55(12) 
F2 C7 C8 F3 -52.99(16)   C3 C2 C6 O1 -20.13(18) 
F2 C7 C8 F4 -173.97(12)   C3 C2 C6 C7 99.78(14) 
F2 C7 C8 F5 66.92(15)   C6 C7 C8 F3 71.36(16) 
O1 C6 C7 F1 -174.78(10)   C6 C7 C8 F4 -49.63(17) 
O1 C6 C7 F2 67.45(13)   C6 C7 C8 F5 -168.74(12) 
C1 C2 C6 O1 158.88(12)   C8 C7 C6 O1 -54.41(15) 
C1 C2 C6 C7 -81.20(15)             
  
 
Table 8 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 18srv350. 
Atom x y z U(eq) 
H1A 13458.36 6709.86 2739.83 31 
H3 7162.78 9344.83 2521.28 33 
H4 6891.15 8648.99 1378.62 37 
H5 9911.93 6989.3 962.87 36 
H6 12507.67 8580.15 3619.97 28 
H1 10450(40) 10520(20) 3519(10) 53(6) 
Refinement model description  
Number of restraints - 0, number of constraints - unknown.  
Details: 
1. Fixed Uiso 
 At 1.2 times of:  All C(H) groups 
2.a Ternary CH refined with riding coordinates: 
 C6(H6) 
2.b Aromatic/amide H refined with riding coordinates: 
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